{"id":28130,"date":"2025-09-19T12:32:00","date_gmt":"2025-09-19T04:32:00","guid":{"rendered":"https:\/\/www.franchise.com.hk\/%e5%86%8d%e4%b8%8b%e4%b8%80%e5%9f%8e-%e5%be%a9%e5%ae%8f%e6%bc%a2%e9%9c%96%e8%88%87organon%e5%85%b1%e5%90%8c%e5%ae%a3%e4%bd%88%e5%9c%b0%e8%88%92%e5%96%ae%e6%8a%97bildyos%e5%92%8cbilprevda\/28130"},"modified":"2025-09-19T12:32:00","modified_gmt":"2025-09-19T04:32:00","slug":"%e5%86%8d%e4%b8%8b%e4%b8%80%e5%9f%8e-%e5%be%a9%e5%ae%8f%e6%bc%a2%e9%9c%96%e8%88%87organon%e5%85%b1%e5%90%8c%e5%ae%a3%e4%bd%88%e5%9c%b0%e8%88%92%e5%96%ae%e6%8a%97bildyos%e5%92%8cbilprevda","status":"publish","type":"post","link":"https:\/\/www.franchise.com.hk\/en\/%e5%86%8d%e4%b8%8b%e4%b8%80%e5%9f%8e-%e5%be%a9%e5%ae%8f%e6%bc%a2%e9%9c%96%e8%88%87organon%e5%85%b1%e5%90%8c%e5%ae%a3%e4%bd%88%e5%9c%b0%e8%88%92%e5%96%ae%e6%8a%97bildyos%e5%92%8cbilprevda\/28130","title":{"rendered":"\u518d\u4e0b\u4e00\u57ce \u5fa9\u5b8f\u6f22\u9716\u8207Organon\u5171\u540c\u5ba3\u4f48\u5730\u8212\u55ae\u6297BILDYOS\u00ae\u548cBILPREVDA\u00ae\u7372\u6b50\u76df\u6279\u51c6\u4e0a\u5e02"},"content":{"rendered":"<p><span class=\"legendSpanClass\">\u4e0a\u6d77\u548c\u65b0\u6fa4\u897f\u5dde\u6fa4\u897f\u5e02<\/span><span class=\"legendSpanClass\">2025\u5e749\u670819\u65e5<\/span> \/\u7f8e\u901a\u793e\/ &#8212; \u5fa9\u5b8f\u6f22\u9716\uff082696.HK\uff09\u8207Organon\uff08\u7d10\u4ea4\u6240\u4ee3\u78bc\uff1aOGN\uff09\u4eca\u65e5\u806f\u5408\u5ba3\u4f48\uff0c\u6b50\u76df\u59d4\u54e1\u6703\uff08EC\uff09\u5df2\u6279\u51c6\u5730\u8212\u55ae\u6297\u6ce8\u5c04\u6db2\uff0860 mg\/mL\uff09BILDYOS\u00ae\uff08denosumab\uff09\u548c\u5730\u8212\u55ae\u6297\u6ce8\u5c04\u6db2\uff08120mg\/1.7mL\uff09BILPREVDA\u00ae\uff08denosumab\uff09\u7684\u4e0a\u5e02\u8a31\u53ef\uff0c\u5169\u6b3e\u7522\u54c1\u5206\u5225\u70baPROLIA\u00ae\uff08\u5730\u8212\u55ae\u6297\uff09\u548cXGEVA\u00ae\uff08\u5730\u8212\u55ae\u6297\uff09\u7684\u751f\u7269\u985e\u4f3c\u85e5\uff0c\u8986\u84cb\u539f\u7814\u7522\u54c1\u5728\u6b50\u76df\u5df2\u7372\u6279\u7684\u6240\u6709\u9069\u61c9\u75c7[1,2]\u3002<\/p>\n<p>Organon\u570b\u969b\u5546\u696d\u8ca0\u8cac\u4ebaNico Van Hoecke\u8868\u793a\uff1a\u300cBILDYOS\u548cBILPREVDA\u7684\u6b50\u76df\u7372\u6279\uff0c\u6a19\u8a8c\u8457\u6211\u5011\u5728\u70ba\u6578\u767e\u842c\u6b50\u6d32\u60a3\u8005\uff0c\u7279\u5225\u662f\u53d7\u9aa8\u8cea\u758f\u9b06\u75c7\u5f71\u97ff\u6bd4\u4f8b\u66f4\u9ad8\u7684\u5973\u6027\uff0c\u64f4\u5927\u95dc\u9375\u9aa8\u9abc\u5065\u5eb7\u6cbb\u7642\u53ef\u53ca\u6027\u65b9\u9762\u9081\u51fa\u4e86\u95dc\u9375\u4e00\u6b65[3,4]\u3002\u9019\u4e9b\u751f\u7269\u985e\u4f3c\u85e5\u53ef\u70ba\u5305\u62ec\u9aa8\u8cea\u758f\u9b06\u75c7\u5728\u5167\u7684\u9aa8\u8cea\u6d41\u5931\u76f8\u95dc\u7684\u591a\u500b\u6cbb\u7642\u9818\u57df\u63d0\u4f9b\u66f4\u591a\u9078\u64c7\uff0c\u9ad4\u73fe\u4e86Organon\u901a\u904e\u63d0\u5347\u85e5\u7269\u53ef\u53ca\u6027\u4f86\u63a8\u52d5\u5973\u6027\u5065\u5eb7\u7684\u627f\u8afe\u3002\u5728\u7f8e\u570b\u7372\u6279\u4e4b\u5f8c\uff0c\u9019\u6b21\u7684\u6b50\u76df\u6279\u51c6\u4e0d\u50c5\u62d3\u5c55\u4e86\u5169\u6b3e\u751f\u7269\u985e\u4f3c\u85e5\u7684\u5168\u7403\u53ef\u53ca\u7bc4\u570d\uff0c\u540c\u6642\u4e5f\u652f\u6301\u4e86\u6b50\u6d32\u91ab\u7642\u9ad4\u7cfb\u7684\u53ef\u6301\u7e8c\u767c\u5c55[5,6]\u3002\u300d<\/p>\n<p>\u5fa9\u5b8f\u6f22\u9716\u9996\u5e2d\u5546\u52d9\u767c\u5c55\u5b98\u517c\u9ad8\u7d1a\u526f\u7e3d\u88c1\u66f9\u5e73\u8868\u793a\uff1a\u300c\u6b64\u6b21\u7372\u6279\u662f\u5fa9\u5b8f\u6f22\u9716\u8207Organon\u5f37\u5f37\u806f\u5408\u3001\u5171\u540c\u6eff\u8db3\u6b50\u6d32\u60a3\u8005\u548c\u91ab\u7642\u7cfb\u7d71\u9700\u6c42\u7684\u53c8\u4e00\u91cd\u8981\u6210\u679c\u3002\u6191\u501f\u5c0d\u79d1\u5b78\u5353\u8d8a\u8207\u7522\u54c1\u8cea\u91cf\u7684\u59cb\u7d42\u5805\u5b88\uff0c\u6211\u5011\u5728\u7f8e\u570b\u7372\u6279\u7684\u57fa\u790e\u4e0a\u4e0d\u65b7\u524d\u884c\uff0c\u5c07\u9019\u4e9b\u751f\u7269\u985e\u4f3c\u85e5\u6cbb\u7642\u65b9\u6848\u5e36\u7d66\u5168\u7403\u66f4\u591a\u6709\u9700\u8981\u7684\u60a3\u8005[6]\u3002\u300d<\/p>\n<p>BILDYOS\u9069\u7528\u6cbb\u7642\u9aa8\u6298\u9ad8\u98a8\u96aa\u7684\u7d55\u7d93\u5f8c\u5a66\u5973\u53ca\u7537\u6027\u7684\u9aa8\u8cea\u758f\u9b06\u75c7\uff1b\u9aa8\u6298\u9ad8\u98a8\u96aa\u7684\u524d\u5217\u817a\u764c\u7537\u6027\u56e0\u6fc0\u7d20\u525d\u596a\u5c0e\u81f4\u7684\u9aa8\u8cea\u6d41\u5931\uff1b\u4ee5\u53ca\u9aa8\u6298\u9ad8\u98a8\u96aa\u6210\u5e74\u60a3\u8005\u56e0\u9577\u671f\u5168\u8eab\u7cd6\u76ae\u8cea\u6fc0\u7d20\u6cbb\u7642\u5c0e\u81f4\u7684\u9aa8\u8cea\u6d41\u5931\u3002BILPREVDA\u9069\u7528\u65bc\u9810\u9632\u7d2f\u53ca\u9aa8\u9abc\u7684\u665a\u671f\u60e1\u6027\u816b\u7624\u6210\u4eba\u7684\u9aa8\u76f8\u95dc\u4e8b\u4ef6\uff0c\u4ee5\u53ca\u6cbb\u7642\u4e0d\u53ef\u624b\u8853\u5207\u9664\u6216\u624b\u8853\u5207\u9664\u5f8c\u53ef\u80fd\u5c0e\u81f4\u56b4\u91cd\u529f\u80fd\u969c\u7919\u7684\u9aa8\u9245\u7d30\u80de\u7624\u60a3\u8005\uff0c\u5305\u62ec\u6210\u4eba\u548c\u9aa8\u9abc\u767c\u80b2\u6210\u719f\u7684\u9752\u5c11\u5e74\u60a3\u8005\u3002<\/p>\n<p>BILDYOS\u548cBILPREVDA\u7684\u7372\u6279\u662f\u57fa\u65bc\u4e00\u6574\u5957\u5168\u9762\u6578\u64da\u7684\u5be9\u67e5\uff0c\u5176\u4e2d\u5305\u62ec\u7d50\u69cb\u8207\u529f\u80fd\u5206\u6790\u6578\u64da\u3001\u81e8\u5e8a\u85e5\u4ee3\u52d5\u529b\u5b78\u6578\u64da\uff0c\u4ee5\u53ca\u4e00\u9805\u81e8\u5e8a\u5c0d\u6bd4\u7814\u7a76\u3002\u7814\u7a76\u8868\u660e\uff0cBILDYOS\u548cBILPREVDA\u5728\u7d50\u69cb\u3001\u751f\u7269\u6d3b\u6027\u4ee5\u53ca\u7642\u6548\u3001\u5b89\u5168\u6027\u548c\u514d\u75ab\u539f\u6027\u7279\u5fb5\uff08\u86cb\u767d\u548c\u5176\u4ed6\u751f\u7269\u85e5\u7269\u8a98\u767c\u514d\u75ab\u61c9\u7b54\u6216\u514d\u75ab\u76f8\u95dc\u4e8b\u4ef6\u7684\u80fd\u529b\uff09\u65b9\u9762\u8207\u6b50\u76df\u5df2\u6279\u51c6\u7684\u53e6\u4e00\u7a2e\u751f\u7269\u85e5\uff08\u5373\u300c\u539f\u7814\u7522\u54c1\u300d\uff09\u9ad8\u5ea6\u76f8\u4f3c\u3002<\/p>\n<p>2022\u5e74\uff0c\u5fa9\u5b8f\u6f22\u9716\u8207Organon\u7c3d\u8a02\u8a31\u53ef\u8207\u4f9b\u61c9\u5354\u8b70\uff0c\u6388\u4e88Organon\u5c0d\u5305\u62ecBILDYOS\u548cBILPREVDA\u5728\u5167\u7684\u591a\u500b\u751f\u7269\u985e\u4f3c\u85e5\u5728\u9664\u4e2d\u570b\u4ee5\u5916\u7684\u5168\u7403\u5340\u57df\u7684\u7368\u5bb6\u5546\u696d\u5316\u6b0a\u76ca[7]\u3002<\/p>\n<p>\u53c3\u8003\u6587\u737b\uff1a<\/p>\n<p>PROLIA. Product Information. Amgen; 2025.   XGEVA. Product Information. Amgen; 2025.   J. Kanis, Norton, N., Harvey, N., et al. SCOPE 2021: a new scorecard for osteoporosis in <span class=\"xn-location\">Europe<\/span>. Archives of Osteoporosis. (2021) 16:82. Accessed <span class=\"xn-chron\">September 15, 2025<\/span>. Available at <a href=\"https:\/\/www.osteoporosis.foundation\/sites\/iofbonehealth\/files\/202106\/Kanis2021_Article_SCOPE2021ANewScorecardForOsteo.pdf\" target=\"_blank\" rel=\"noopener\">https:\/\/www.osteoporosis.foundation\/sites\/iofbonehealth\/files\/202106\/Kanis2021_Article_SCOPE2021ANewScorecardForOsteo.pdf<\/a><br \/>\n   Biosimilar medicines: overview. European Medicines Agency (EMA). <span class=\"xn-chron\">April 2, 2025<\/span>. Accessed <span class=\"xn-chron\">September 15, 2025<\/span>. <a href=\"https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/biosimilar-medicines-overview\" target=\"_blank\" rel=\"noopener\">https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/biosimilar-medicines-overview<\/a>.\u00a0   Troein P, <span class=\"xn-person\">Max Newton<\/span>, Stoddart K, Travaglio M, <span class=\"xn-person\">Aurelio Arias<\/span>. The impact of biosimilar competition in <span class=\"xn-location\">Europe<\/span>. 2025. Accessed <span class=\"xn-chron\">September 15, 2025<\/span>. <a href=\"https:\/\/www.iqvia.com\/-\/media\/iqvia\/pdfs\/library\/white-papers\/the-impact-of-biosimilar-competition-in-europe-2024.pdf\" target=\"_blank\" rel=\"noopener\">https:\/\/www.iqvia.com\/-\/media\/iqvia\/pdfs\/library\/white-papers\/the-impact-of-biosimilar-competition-in-europe-2024.pdf<\/a>.\u00a0   US Food and Drug Administration (FDA) Approves Henlius and Organon&#8217;s BILDYOS\u00ae (denosumab-nxxp) and BILPREVDA\u00ae (denosumab-nxxp), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively. Organon. Published <span class=\"xn-chron\">September 2, 2025<\/span>. Accessed <span class=\"xn-chron\">September 15<\/span>, 2025.\u00a0<a href=\"https:\/\/www.organon.com\/news\/us-food-and-drug-administration-fda-approves-henlius-and-organons-bildyos-denosumab-nxxp-and-bilprevda-denosumab-nxxp-biosimilars-to-prolia-denosumab-and-xgeva-denosumab\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.organon.com\/news\/us-food-and-drug-administration-fda-approves-henlius-and-organons-bildyos-denosumab-nxxp-and-bilprevda-denosumab-nxxp-biosimilars-to-prolia-denosumab-and-xgeva-denosumab\/<\/a><br \/>\n   Organon Enters into Global License Agreement to Commercialize Henlius&#8217; Investigational Perjeta\u00a0\u00ae(Pertuzumab) and Prolia \u00ae\/Xgeva \u00ae(Denosumab) Biosimilar Candidates. Organon. <span class=\"xn-chron\">June 13, 2022<\/span>. Accessed <span class=\"xn-chron\">September 15, 2025<\/span>. <a href=\"https:\/\/www.organon.com\/news\/organon-enters-into-global-license-agreement-to-commercialize-henlius-investigational-perjeta-pertuzumab-and-prolia-xgeva-denosumab-biosimilar-candidates\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.organon.com\/news\/organon-enters-into-global-license-agreement-to-commercialize-henlius-investigational-perjeta-pertuzumab-and-prolia-xgeva-denosumab-biosimilar-candidates\/<\/a>\u00a0  <\/p>\n<p>\u95dc\u65bc\u5fa9\u5b8f\u6f22\u9716<\/p>\n<p>\u5fa9\u5b8f\u6f22\u9716\uff082696.HK\uff09\u662f\u4e00\u5bb6\u570b\u969b\u5316\u7684\u5275\u65b0\u751f\u7269\u88fd\u85e5\u516c\u53f8\uff0c\u81f4\u529b\u65bc\u70ba\u5168\u7403\u60a3\u8005\u63d0\u4f9b\u53ef\u8ca0\u64d4\u7684\u9ad8\u54c1\u8cea\u751f\u7269\u85e5\uff0c\u7522\u54c1\u8986\u84cb\u816b\u7624\u3001\u81ea\u8eab\u514d\u75ab\u75be\u75c5\u3001\u773c\u79d1\u75be\u75c5\u7b49\u9818\u57df\uff0c\u5df2\u5728\u5168\u7403\u7372\u6279\u4e0a\u5e029\u6b3e\u7522\u54c1\uff0c4\u500b\u4e0a\u5e02\u7533\u8acb\u5206\u5225\u7372\u4e2d\u570b\u85e5\u76e3\u5c40\u3001\u7f8e\u570bFDA\u548c\u6b50\u76dfEMA\u53d7\u7406\u3002\u81ea2010\u5e74\u6210\u7acb\u4ee5\u4f86\uff0c\u5fa9\u5b8f\u6f22\u9716\u5df2\u5efa\u6210\u4e00\u9ad4\u5316\u751f\u7269\u88fd\u85e5\u5e73\u53f0\uff0c\u9ad8\u6548\u53ca\u5275\u65b0\u7684\u81ea\u4e3b\u6838\u5fc3\u80fd\u529b\u8cab\u7a7f\u7814\u767c\u3001\u751f\u7522\u53ca\u5546\u696d\u904b\u71df\u5168\u7522\u696d\u93c8\u3002\u516c\u53f8\u5df2\u5efa\u7acb\u5b8c\u5584\u9ad8\u6548\u7684\u5168\u7403\u5275\u65b0\u4e2d\u5fc3\uff0c\u6309\u7167\u570b\u969b\u85e5\u54c1\u751f\u7522\u8cea\u91cf\u7ba1\u7406\u898f\u7bc4\uff08GMP\uff09\u6a19\u6e96\u9032\u884c\u751f\u7522\u548c\u8cea\u91cf\u7ba1\u63a7\uff0c\u4e0d\u65b7\u592f\u5be6\u4e00\u9ad4\u5316\u7d9c\u5408\u751f\u7522\u5e73\u53f0\uff0c\u5176\u4e2d\uff0c\u516c\u53f8\u5546\u696d\u5316\u751f\u7522\u57fa\u5730\u5df2\u76f8\u7e7c\u7372\u5f97\u4e2d\u570b\u3001\u6b50\u76df\u548c\u7f8e\u570bGMP\u8a8d\u8b49\u3002<\/p>\n<p>\u5fa9\u5b8f\u6f22\u9716\u524d\u77bb\u6027\u4f48\u5c40\u4e86\u4e00\u500b\u591a\u5143\u5316\u3001\u9ad8\u8cea\u91cf\u7684\u7522\u54c1\u7ba1\u7dda\uff0c\u6db5\u84cb\u7d0450\u500b\u5206\u5b50\uff0c\u4e26\u5168\u9762\u63a8\u9032\u57fa\u65bc\u81ea\u6709\u6297PD-1\u55ae\u6297H\u85e5\u6f22\u65af\u72c0\u00ae\u7684\u816b\u7624\u514d\u75ab\u806f\u5408\u7642\u6cd5\u3002\u622a\u81f3\u76ee\u524d\uff0c\u516c\u53f8\u5df2\u7372\u6279\u4e0a\u5e02\u7522\u54c1\u5305\u62ec\u5168\u7403\u9996\u500b\u7372\u6279\u4e00\u7dda\u6cbb\u7642\u5c0f\u7d30\u80de\u80ba\u764c\u7684\u6297PD-1\u55ae\u6297\u6f22\u65af\u72c0\u00ae\uff08\u65af\u9b6f\u5229\u55ae\u6297\uff0c\u6b50\u6d32\u5546\u54c1\u540d\uff1aHetronifly\u00ae\uff09\u3001\u81ea\u4e3b\u7814\u767c\u7684\u4e2d\u7f8e\u6b50\u4e09\u5730\u7372\u6279\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5\u6f22\u66f2\u512a\u00ae\uff08\u66f2\u59a5\u73e0\u55ae\u6297\uff0c\u7f8e\u570b\u5546\u54c1\u540d\uff1aHERCESSI\u2122\uff0c\u6b50\u6d32\u5546\u54c1\u540d\uff1aZercepac\u00ae\uff09\u3001\u570b\u5167\u9996\u500b\u751f\u7269\u985e\u4f3c\u85e5\u6f22\u5229\u5eb7\u00ae\uff08\u5229\u59a5\u6614\u55ae\u6297\uff09\u3001\u4ee5\u53ca\u5730\u8212\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5Bildyos\u00ae\u548cBilprevda\u00ae\u3002\u516c\u53f8\u4ea6\u540c\u6b65\u5c3119\u500b\u7522\u54c1\u5728\u5168\u7403\u7bc4\u570d\u5167\u958b\u5c5530\u591a\u9805\u81e8\u5e8a\u8a66\u9a57\uff0c\u5c0d\u5916\u6388\u6b0a\u5168\u9762\u8986\u84cb\u6b50\u7f8e\u4e3b\u6d41\u751f\u7269\u85e5\u5e02\u5834\u548c\u773e\u591a\u65b0\u8208\u5e02\u5834\u3002<\/p>\n<p>\u95dc\u65bc Organon<\/p>\n<p>Organon\uff08\u7d10\u7d04\u8b49\u5238\u4ea4\u6613\u6240\u4ee3\u78bc\uff1aOGN\uff09\u662f\u4e00\u5bb6\u5168\u7403\u5316\u91ab\u7642\u5065\u5eb7\u516c\u53f8\uff0c\u4f7f\u547d\u662f\u63d0\u4f9b\u6709\u6df1\u9060\u5f71\u97ff\u7684\u85e5\u7269\u8207\u89e3\u6c7a\u65b9\u6848\uff0c\u8b93\u4eba\u5011\u7684\u6bcf\u4e00\u5929\u66f4\u5065\u5eb7\u3002\u516c\u53f8\u5c08\u6ce8\u65bc\u89e3\u6c7a\u7368\u7279\uff0c\u91cd\u9ede\uff0c\u6216\u4ee5\u4e0d\u540c\u65b9\u5f0f\u5f71\u97ff\u5973\u6027\u7684\u5065\u5eb7\u9700\u6c42\uff0c\u63d0\u4f9b\u8d85\u904e70\u7a2e\u5973\u6027\u5065\u5eb7\u8207\u5e38\u898f\u85e5\u7269\u7684\u7522\u54c1\u7d44\u5408\uff0c\u5176\u4e2d\u5305\u62ec\u751f\u7269\u985e\u4f3c\u85e5\uff0c\u540c\u6642\u5728\u5168\u7403140\u591a\u500b\u5e02\u5834\u64f4\u5927\u57fa\u672c\u6cbb\u7642\u624b\u6bb5\u7684\u53ef\u53ca\u6027\u3002<\/p>\n<p>\u516c\u53f8\u7e3d\u90e8\u4f4d\u65bc\u65b0\u6fa4\u897f\u5dde\u6fa4\u897f\u5e02\u3002Organon \u81f4\u529b\u65bc\u63a8\u52d5\u91ab\u7642\u7684\u53ef\u53ca\u6027\u3001\u53ef\u8ca0\u64d4\u6027\u8207\u5275\u65b0\u3002\u66f4\u591a\u4fe1\u606f\u8acb\u8a2a\u554f <a href=\"http:\/\/www.organon.com\/\" target=\"_blank\" rel=\"noopener\">www.organon.com<\/a>\uff0c\u4e26\u95dc\u6ce8\u6211\u5011\u7684 LinkedIn\u3001Instagram\u3001X\u3001YouTube\u3001TikTok \u548c Facebook\u3002<\/p>\n<p>\u95dc\u65bc\u524d\u77bb\u6027\u8072\u660e\u7684\u6ce8\u610f\u4e8b\u9805 <\/p>\n<p>\u9664\u6b77\u53f2\u4fe1\u606f\u5916\uff0c\u672c\u65b0\u805e\u7a3f\u5305\u542b\u7684\u67d0\u4e9b\u9673\u8ff0\u548c\u62ab\u9732\u5c6c\u65bc1995\u5e74\u300a\u7f8e\u570b\u79c1\u4eba\u8b49\u5238\u8a34\u8a1f\u6539\u9769\u6cd5\u6848\u300b\u5b89\u5168\u6e2f\u689d\u6b3e\u6240\u6307\u7684\u300c\u524d\u77bb\u6027\u9673\u8ff0\u300d\uff0c\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\u6709\u95dcBILDYOS\u548cBILPREVDA\u696d\u52d9\u6a5f\u6703\u53ca\u5e02\u5834\u524d\u666f\u9810\u671f\u7684\u76f8\u95dc\u8868\u8ff0\u3002\u524d\u77bb\u6027\u9673\u8ff0\u53ef\u901a\u904e\u300c\u5c07\u6703\u300d\u3001\u300c\u6f5b\u5728\u300d\u3001\u300c\u76ee\u6a19\u300d\u3001\u300c\u63a2\u7d22\u300d\u3001\u300c\u6a5f\u6703\u300d\u3001\u300c\u9810\u671f\u300d\u3001\u300c\u672a\u4f86\u300d\u6216\u5177\u6709\u985e\u4f3c\u542b\u7fa9\u7684\u63aa\u8fad\u8b58\u5225\u3002\u9019\u4e9b\u524d\u77bb\u6027\u9673\u8ff0\u57fa\u65bcOrganon\u7ba1\u7406\u5c64\u7576\u524d\u7684\u8a08\u5283\u548c\u9810\u671f\uff0c\u4e26\u53d7\u5230\u91cd\u5927\u98a8\u96aa\u548c\u4e0d\u78ba\u5b9a\u6027\u7684\u5f71\u97ff\uff0c\u5982\u57fa\u672c\u5047\u5b9a\u4e0d\u6e96\u78ba\u6216\u98a8\u96aa\u6216\u4e0d\u78ba\u5b9a\u6027\u6210\u70ba\u73fe\u5be6\uff0c\u5be6\u969b\u7d50\u679c\u53ef\u80fd\u8207\u524d\u77bb\u6027\u8072\u660e\u4e2d\u6240\u8ff0\u7684\u7d50\u679c\u6709\u91cd\u5927\u5dee\u7570\u3002\u98a8\u96aa\u548c\u4e0d\u78ba\u5b9a\u6027\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\uff1a\u7121\u6cd5\u63a8\u5ee3 BILDYOS \u548c BILPREVDA\uff1b\u53ef\u80fd\u4e0d\u5229\u5f71\u97ff\u5176\u5e02\u5834\u9700\u6c42\u7684\u56e0\u7d20\uff08\u5305\u62ec\u8cbf\u6613\u4fdd\u8b77\u63aa\u65bd\u53ca\u9032\u51fa\u53e3\u8a31\u53ef\u8981\u6c42\u3001\u7f8e\u570b\u53ca\u5176\u4ed6\u570b\u5bb6\u6216\u5730\u5340\u5728\u806f\u90a6\u3001\u5dde\u53ca\u5730\u65b9\u5c64\u9762\u7684\u653f\u5e9c\u8cc7\u91d1\u5206\u914d\u8b8a\u5316\u2014\u2014\u5305\u62ec\u5206\u914d\u7d66 Organon \u5ba2\u6236\u53ca\u696d\u52d9\u5925\u4f34\u7684\u6642\u9593\u548c\u91d1\u984d\uff0c\u4ee5\u53ca\u7d93\u6fdf\u56e0\u7d20\uff09\uff1b\u4efb\u4f55\u4f9b\u61c9\u5546\u672a\u80fd\u6309\u7d04\u63d0\u4f9b\u7269\u8cea\u3001\u6750\u6599\u6216\u670d\u52d9\uff1b\u4f9b\u61c9\u3001\u751f\u7522\u3001\u5305\u88dd\u548c\u904b\u71df\u6210\u672c\u7684\u589e\u52a0\uff1b\u5168\u7403\u7bc4\u570d\u5167\u7684\u5b9a\u50f9\u58d3\u529b\uff0c\u5305\u62ec\u91ab\u7642\u4fdd\u96aa\u7ba1\u7406\u7d44\u7e54\u7684\u898f\u5247\u8207\u505a\u6cd5\u3001\u53f8\u6cd5\u5224\u6c7a\u4ee5\u53ca\u8207\u91ab\u4fdd\uff08Medicare\uff09\u3001\u91ab\u7642\u88dc\u52a9\uff08Medicaid\uff09\u53ca\u91ab\u7642\u6539\u9769\u76f8\u95dc\u7684\u653f\u5e9c\u6cd5\u5f8b\u6cd5\u898f\uff0c\u4ee5\u53ca\u85e5\u54c1\u88dc\u511f\u8207\u5b9a\u50f9\u7e3d\u9ad4\u74b0\u5883\uff1b\u751f\u7522\u56f0\u96e3\u6216\u5ef6\u9072\uff1b\u7f8e\u570b FDA \u6216\u5176\u4ed6\u653f\u5e9c\u6a5f\u69cb\u7684\u91cd\u7d44\u6216\u5176\u4ed6\u5e72\u64fe\uff1b\u7642\u6548\u3001\u5b89\u5168\u6027\u6216\u5176\u4ed6\u8cea\u91cf\u65b9\u9762\u7684\u9867\u616e\uff1b\u4ee5\u53ca\u7b2c\u4e09\u65b9\u672a\u4f86\u7684\u884c\u52d5\uff0c\u5305\u62ec\u5ba2\u6236\u95dc\u4fc2\u7684\u91cd\u5927\u8b8a\u5316\uff0c\u6216\u91ab\u7642\u7522\u54c1\u8207\u670d\u52d9\u8cfc\u8cb7\u8005\u7684\u884c\u70ba\u8207\u6d88\u8cbb\u6a21\u5f0f\u7684\u8b8a\u5316\uff0c\u4f8b\u5982\u63a8\u9072\u91ab\u7642\u7a0b\u5e8f\u3001\u9650\u5236\u8655\u65b9\u85e5\u4f7f\u7528\u3001\u6e1b\u5c11\u5c31\u8a3a\u983b\u7387\uff0c\u4ee5\u53ca\u653e\u68c4\u91ab\u7642\u4fdd\u96aa\u8986\u84cb\u7b49\u3002Organon \u6c92\u6709\u7fa9\u52d9\u56e0\u65b0\u4fe1\u606f\u3001\u672a\u4f86\u4e8b\u4ef6\u6216\u5176\u4ed6\u539f\u56e0\u800c\u516c\u958b\u66f4\u65b0\u4efb\u4f55\u524d\u77bb\u6027\u8072\u660e\u3002\u5c0e\u81f4\u7d50\u679c\u8207\u524d\u77bb\u6027\u8072\u660e\u6240\u8ff0\u5b58\u5728\u91cd\u5927\u5dee\u7570\u7684\u5176\u4ed6\u56e0\u7d20\uff0c\u53ef\u898b\u65bc Organon \u5411\u7f8e\u570b\u8b49\u5238\u4ea4\u6613\u59d4\u54e1\u6703\uff08SEC\uff09\u63d0\u4ea4\u7684\u6587\u4ef6\uff0c\u5305\u62ec Organon \u6700\u65b0\u7684\u5e74\u5ea6\u5831\u544a Form 10-K \u53ca\u5176\u5f8c\u7e8c\u6587\u4ef6\uff08\u5305\u62ec\u622a\u81f3 2025 \u5e74 6 \u6708 30 \u65e5\u5b63\u5ea6\u7684\u5b63\u5ea6\u5831\u544a Form 10-Q\uff09\uff0c\u53ef\u5728 SEC \u7db2\u7ad9 (<a href=\"http:\/\/www.sec.gov\/\" target=\"_blank\" rel=\"noopener\">www.sec.gov<\/a>) \u67e5\u95b1\u3002\u6240\u63d0\u4f9b\u7684\u53c3\u8003\u8207\u7db2\u7ad9\u93c8\u63a5\u50c5\u70ba\u65b9\u4fbf\u8d77\u898b\uff0c\u4efb\u4f55\u6b64\u985e\u7db2\u7ad9\u6240\u8f09\u4fe1\u606f\u5747\u4e0d\u69cb\u6210\u672c\u65b0\u805e\u7a3f\u7684\u4e00\u90e8\u5206\uff0c\u4e5f\u4e0d\u88ab\u8996\u70ba\u5f15\u7528\u4f75\u5165\u672c\u65b0\u805e\u7a3f\u3002Organon \u5c0d\u7b2c\u4e09\u65b9\u7db2\u7ad9\u5167\u5bb9\u4e0d\u627f\u64d4\u8cac\u4efb\u3002<\/p>\n<p>PROLIA \u548c XGEVA \u70ba\u5b89\u9032\u516c\u53f8\uff08Amgen, Inc.\uff09\u5728\u6b50\u6d32\u8a3b\u518a\u7684\u5546\u6a19\uff1bOrganon \u8207\u8a72\u5546\u6a19\u6301\u6709\u4eba\u4e0d\u5b58\u5728\u4efb\u4f55\u95dc\u806f\u3002<\/p>","protected":false},"excerpt":{"rendered":"<p>\u4e0a\u6d77\u548c\u65b0\u6fa4\u897f\u5dde\u6fa4\u897f\u5e022025\u5e749\u670819\u65e5 \/\u7f8e\u901a\u793e\/ &#8212; \u5fa9\u5b8f\u6f22\u9716\uff082696.HK\uff09\u8207Organon\uff08\u7d10\u4ea4\u6240\u4ee3\u78bc\uff1aOGN\uff09\u4eca\u65e5\u806f\u5408\u5ba3\u4f48\uff0c\u6b50\u76df\u59d4\u54e1\u6703\uff08EC\uff09\u5df2\u6279\u51c6\u5730\u8212\u55ae\u6297\u6ce8\u5c04\u6db2\uff0860 mg\/mL\uff09BILDYOS\u00ae\uff08denosumab\uff09\u548c\u5730\u8212\u55ae\u6297\u6ce8\u5c04\u6db2\uff08120mg\/1.7mL\uff09BILPREVDA\u00ae\uff08denosumab\uff09\u7684\u4e0a\u5e02\u8a31\u53ef\uff0c\u5169\u6b3e\u7522\u54c1\u5206\u5225\u70baPROLIA\u00ae\uff08\u5730\u8212\u55ae\u6297\uff09\u548cXGEVA\u00ae\uff08\u5730\u8212\u55ae\u6297\uff09\u7684\u751f\u7269\u985e\u4f3c\u85e5\uff0c\u8986\u84cb\u539f\u7814\u7522\u54c1\u5728\u6b50\u76df\u5df2\u7372\u6279\u7684\u6240\u6709\u9069\u61c9\u75c7[1,2]\u3002 Organon\u570b\u969b\u5546\u696d\u8ca0\u8cac\u4ebaNico Van Hoecke\u8868\u793a\uff1a\u300cBILDYOS\u548cBILPREVDA\u7684\u6b50\u76df\u7372\u6279\uff0c\u6a19\u8a8c\u8457\u6211\u5011\u5728\u70ba\u6578\u767e\u842c\u6b50\u6d32\u60a3\u8005\uff0c\u7279\u5225\u662f\u53d7\u9aa8\u8cea\u758f\u9b06\u75c7\u5f71\u97ff\u6bd4\u4f8b\u66f4\u9ad8\u7684\u5973\u6027\uff0c\u64f4\u5927\u95dc\u9375\u9aa8\u9abc\u5065\u5eb7\u6cbb\u7642\u53ef\u53ca\u6027\u65b9\u9762\u9081\u51fa\u4e86\u95dc\u9375\u4e00\u6b65[3,4]\u3002\u9019\u4e9b\u751f\u7269\u985e\u4f3c\u85e5\u53ef\u70ba\u5305\u62ec\u9aa8\u8cea\u758f\u9b06\u75c7\u5728\u5167\u7684\u9aa8\u8cea\u6d41\u5931\u76f8\u95dc\u7684\u591a\u500b\u6cbb\u7642\u9818\u57df\u63d0\u4f9b\u66f4\u591a\u9078\u64c7\uff0c\u9ad4\u73fe\u4e86Organon\u901a\u904e\u63d0\u5347\u85e5\u7269\u53ef\u53ca\u6027\u4f86\u63a8\u52d5\u5973\u6027\u5065\u5eb7\u7684\u627f\u8afe\u3002\u5728\u7f8e\u570b\u7372\u6279\u4e4b\u5f8c\uff0c\u9019\u6b21\u7684\u6b50\u76df\u6279\u51c6\u4e0d\u50c5\u62d3\u5c55\u4e86\u5169\u6b3e\u751f\u7269\u985e\u4f3c\u85e5\u7684\u5168\u7403\u53ef\u53ca\u7bc4\u570d\uff0c\u540c\u6642\u4e5f\u652f\u6301\u4e86\u6b50\u6d32\u91ab\u7642\u9ad4\u7cfb\u7684\u53ef\u6301\u7e8c\u767c\u5c55[5,6]\u3002\u300d \u5fa9\u5b8f\u6f22\u9716\u9996\u5e2d\u5546\u52d9\u767c\u5c55\u5b98\u517c\u9ad8\u7d1a\u526f\u7e3d\u88c1\u66f9\u5e73\u8868\u793a\uff1a\u300c\u6b64\u6b21\u7372\u6279\u662f\u5fa9\u5b8f\u6f22\u9716\u8207Organon\u5f37\u5f37\u806f\u5408\u3001\u5171\u540c\u6eff\u8db3\u6b50\u6d32\u60a3\u8005\u548c\u91ab\u7642\u7cfb\u7d71\u9700\u6c42\u7684\u53c8\u4e00\u91cd\u8981\u6210\u679c\u3002\u6191\u501f\u5c0d\u79d1\u5b78\u5353\u8d8a\u8207\u7522\u54c1\u8cea\u91cf\u7684\u59cb\u7d42\u5805\u5b88\uff0c\u6211\u5011\u5728\u7f8e\u570b\u7372\u6279\u7684\u57fa\u790e\u4e0a\u4e0d\u65b7\u524d\u884c\uff0c\u5c07\u9019\u4e9b\u751f\u7269\u985e\u4f3c\u85e5\u6cbb\u7642\u65b9\u6848\u5e36\u7d66\u5168\u7403\u66f4\u591a\u6709\u9700\u8981\u7684\u60a3\u8005[6]\u3002\u300d BILDYOS\u9069\u7528\u6cbb\u7642\u9aa8\u6298\u9ad8\u98a8\u96aa\u7684\u7d55\u7d93\u5f8c\u5a66\u5973\u53ca\u7537\u6027\u7684\u9aa8\u8cea\u758f\u9b06\u75c7\uff1b\u9aa8\u6298\u9ad8\u98a8\u96aa\u7684\u524d\u5217\u817a\u764c\u7537\u6027\u56e0\u6fc0\u7d20\u525d\u596a\u5c0e\u81f4\u7684\u9aa8\u8cea\u6d41\u5931\uff1b\u4ee5\u53ca\u9aa8\u6298\u9ad8\u98a8\u96aa\u6210\u5e74\u60a3\u8005\u56e0\u9577\u671f\u5168\u8eab\u7cd6\u76ae\u8cea\u6fc0\u7d20\u6cbb\u7642\u5c0e\u81f4\u7684\u9aa8\u8cea\u6d41\u5931\u3002BILPREVDA\u9069\u7528\u65bc\u9810\u9632\u7d2f\u53ca\u9aa8\u9abc\u7684\u665a\u671f\u60e1\u6027\u816b\u7624\u6210\u4eba\u7684\u9aa8\u76f8\u95dc\u4e8b\u4ef6\uff0c\u4ee5\u53ca\u6cbb\u7642\u4e0d\u53ef\u624b\u8853\u5207\u9664\u6216\u624b\u8853\u5207\u9664\u5f8c\u53ef\u80fd\u5c0e\u81f4\u56b4\u91cd\u529f\u80fd\u969c\u7919\u7684\u9aa8\u9245\u7d30\u80de\u7624\u60a3\u8005\uff0c\u5305\u62ec\u6210\u4eba\u548c\u9aa8\u9abc\u767c\u80b2\u6210\u719f\u7684\u9752\u5c11\u5e74\u60a3\u8005\u3002 BILDYOS\u548cBILPREVDA\u7684\u7372\u6279\u662f\u57fa\u65bc\u4e00\u6574\u5957\u5168\u9762\u6578\u64da\u7684\u5be9\u67e5\uff0c\u5176\u4e2d\u5305\u62ec\u7d50\u69cb\u8207\u529f\u80fd\u5206\u6790\u6578\u64da\u3001\u81e8\u5e8a\u85e5\u4ee3\u52d5\u529b\u5b78\u6578\u64da\uff0c\u4ee5\u53ca\u4e00\u9805\u81e8\u5e8a\u5c0d\u6bd4\u7814\u7a76\u3002\u7814\u7a76\u8868\u660e\uff0cBILDYOS\u548cBILPREVDA\u5728\u7d50\u69cb\u3001\u751f\u7269\u6d3b\u6027\u4ee5\u53ca\u7642\u6548\u3001\u5b89\u5168\u6027\u548c\u514d\u75ab\u539f\u6027\u7279\u5fb5\uff08\u86cb\u767d\u548c\u5176\u4ed6\u751f\u7269\u85e5\u7269\u8a98\u767c\u514d\u75ab\u61c9\u7b54\u6216\u514d\u75ab\u76f8\u95dc\u4e8b\u4ef6\u7684\u80fd\u529b\uff09\u65b9\u9762\u8207\u6b50\u76df\u5df2\u6279\u51c6\u7684\u53e6\u4e00\u7a2e\u751f\u7269\u85e5\uff08\u5373\u300c\u539f\u7814\u7522\u54c1\u300d\uff09\u9ad8\u5ea6\u76f8\u4f3c\u3002 2022\u5e74\uff0c\u5fa9\u5b8f\u6f22\u9716\u8207Organon\u7c3d\u8a02\u8a31\u53ef\u8207\u4f9b\u61c9\u5354\u8b70\uff0c\u6388\u4e88Organon\u5c0d\u5305\u62ecBILDYOS\u548cBILPREVDA\u5728\u5167\u7684\u591a\u500b\u751f\u7269\u985e\u4f3c\u85e5\u5728\u9664\u4e2d\u570b\u4ee5\u5916\u7684\u5168\u7403\u5340\u57df\u7684\u7368\u5bb6\u5546\u696d\u5316\u6b0a\u76ca[7]\u3002 \u53c3\u8003\u6587\u737b\uff1a PROLIA. Product Information. Amgen; 2025. XGEVA. Product Information. Amgen; 2025. J. Kanis, Norton, N., Harvey, N., et al. SCOPE 2021: a new scorecard for osteoporosis in Europe. Archives of Osteoporosis. (2021) 16:82. Accessed September 15, 2025. Available at https:\/\/www.osteoporosis.foundation\/sites\/iofbonehealth\/files\/202106\/Kanis2021_Article_SCOPE2021ANewScorecardForOsteo.pdf Biosimilar medicines: overview. European Medicines Agency (EMA). April 2, 2025. Accessed September 15, 2025. https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/biosimilar-medicines-overview.\u00a0 Troein P, Max Newton, Stoddart K, Travaglio M, Aurelio Arias. The impact of biosimilar competition in Europe. 2025. Accessed September 15, 2025. https:\/\/www.iqvia.com\/-\/media\/iqvia\/pdfs\/library\/white-papers\/the-impact-of-biosimilar-competition-in-europe-2024.pdf.\u00a0 US Food and Drug Administration (FDA) Approves Henlius and Organon&#8217;s BILDYOS\u00ae (denosumab-nxxp) and BILPREVDA\u00ae (denosumab-nxxp), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively. Organon. Published September 2, 2025. Accessed September 15, 2025.\u00a0https:\/\/www.organon.com\/news\/us-food-and-drug-administration-fda-approves-henlius-and-organons-bildyos-denosumab-nxxp-and-bilprevda-denosumab-nxxp-biosimilars-to-prolia-denosumab-and-xgeva-denosumab\/ Organon Enters into Global License Agreement to Commercialize Henlius&#8217; Investigational Perjeta\u00a0\u00ae(Pertuzumab) and Prolia \u00ae\/Xgeva \u00ae(Denosumab) Biosimilar Candidates. Organon. June 13, 2022. Accessed September 15, 2025. https:\/\/www.organon.com\/news\/organon-enters-into-global-license-agreement-to-commercialize-henlius-investigational-perjeta-pertuzumab-and-prolia-xgeva-denosumab-biosimilar-candidates\/\u00a0 \u95dc\u65bc\u5fa9\u5b8f\u6f22\u9716 \u5fa9\u5b8f\u6f22\u9716\uff082696.HK\uff09\u662f\u4e00\u5bb6\u570b\u969b\u5316\u7684\u5275\u65b0\u751f\u7269\u88fd\u85e5\u516c\u53f8\uff0c\u81f4\u529b\u65bc\u70ba\u5168\u7403\u60a3\u8005\u63d0\u4f9b\u53ef\u8ca0\u64d4\u7684\u9ad8\u54c1\u8cea\u751f\u7269\u85e5\uff0c\u7522\u54c1\u8986\u84cb\u816b\u7624\u3001\u81ea\u8eab\u514d\u75ab\u75be\u75c5\u3001\u773c\u79d1\u75be\u75c5\u7b49\u9818\u57df\uff0c\u5df2\u5728\u5168\u7403\u7372\u6279\u4e0a\u5e029\u6b3e\u7522\u54c1\uff0c4\u500b\u4e0a\u5e02\u7533\u8acb\u5206\u5225\u7372\u4e2d\u570b\u85e5\u76e3\u5c40\u3001\u7f8e\u570bFDA\u548c\u6b50\u76dfEMA\u53d7\u7406\u3002\u81ea2010\u5e74\u6210\u7acb\u4ee5\u4f86\uff0c\u5fa9\u5b8f\u6f22\u9716\u5df2\u5efa\u6210\u4e00\u9ad4\u5316\u751f\u7269\u88fd\u85e5\u5e73\u53f0\uff0c\u9ad8\u6548\u53ca\u5275\u65b0\u7684\u81ea\u4e3b\u6838\u5fc3\u80fd\u529b\u8cab\u7a7f\u7814\u767c\u3001\u751f\u7522\u53ca\u5546\u696d\u904b\u71df\u5168\u7522\u696d\u93c8\u3002\u516c\u53f8\u5df2\u5efa\u7acb\u5b8c\u5584\u9ad8\u6548\u7684\u5168\u7403\u5275\u65b0\u4e2d\u5fc3\uff0c\u6309\u7167\u570b\u969b\u85e5\u54c1\u751f\u7522\u8cea\u91cf\u7ba1\u7406\u898f\u7bc4\uff08GMP\uff09\u6a19\u6e96\u9032\u884c\u751f\u7522\u548c\u8cea\u91cf\u7ba1\u63a7\uff0c\u4e0d\u65b7\u592f\u5be6\u4e00\u9ad4\u5316\u7d9c\u5408\u751f\u7522\u5e73\u53f0\uff0c\u5176\u4e2d\uff0c\u516c\u53f8\u5546\u696d\u5316\u751f\u7522\u57fa\u5730\u5df2\u76f8\u7e7c\u7372\u5f97\u4e2d\u570b\u3001\u6b50\u76df\u548c\u7f8e\u570bGMP\u8a8d\u8b49\u3002 \u5fa9\u5b8f\u6f22\u9716\u524d\u77bb\u6027\u4f48\u5c40\u4e86\u4e00\u500b\u591a\u5143\u5316\u3001\u9ad8\u8cea\u91cf\u7684\u7522\u54c1\u7ba1\u7dda\uff0c\u6db5\u84cb\u7d0450\u500b\u5206\u5b50\uff0c\u4e26\u5168\u9762\u63a8\u9032\u57fa\u65bc\u81ea\u6709\u6297PD-1\u55ae\u6297H\u85e5\u6f22\u65af\u72c0\u00ae\u7684\u816b\u7624\u514d\u75ab\u806f\u5408\u7642\u6cd5\u3002\u622a\u81f3\u76ee\u524d\uff0c\u516c\u53f8\u5df2\u7372\u6279\u4e0a\u5e02\u7522\u54c1\u5305\u62ec\u5168\u7403\u9996\u500b\u7372\u6279\u4e00\u7dda\u6cbb\u7642\u5c0f\u7d30\u80de\u80ba\u764c\u7684\u6297PD-1\u55ae\u6297\u6f22\u65af\u72c0\u00ae\uff08\u65af\u9b6f\u5229\u55ae\u6297\uff0c\u6b50\u6d32\u5546\u54c1\u540d\uff1aHetronifly\u00ae\uff09\u3001\u81ea\u4e3b\u7814\u767c\u7684\u4e2d\u7f8e\u6b50\u4e09\u5730\u7372\u6279\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5\u6f22\u66f2\u512a\u00ae\uff08\u66f2\u59a5\u73e0\u55ae\u6297\uff0c\u7f8e\u570b\u5546\u54c1\u540d\uff1aHERCESSI\u2122\uff0c\u6b50\u6d32\u5546\u54c1\u540d\uff1aZercepac\u00ae\uff09\u3001\u570b\u5167\u9996\u500b\u751f\u7269\u985e\u4f3c\u85e5\u6f22\u5229\u5eb7\u00ae\uff08\u5229\u59a5\u6614\u55ae\u6297\uff09\u3001\u4ee5\u53ca\u5730\u8212\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5Bildyos\u00ae\u548cBilprevda\u00ae\u3002\u516c\u53f8\u4ea6\u540c\u6b65\u5c3119\u500b\u7522\u54c1\u5728\u5168\u7403\u7bc4\u570d\u5167\u958b\u5c5530\u591a\u9805\u81e8\u5e8a\u8a66\u9a57\uff0c\u5c0d\u5916\u6388\u6b0a\u5168\u9762\u8986\u84cb\u6b50\u7f8e\u4e3b\u6d41\u751f\u7269\u85e5\u5e02\u5834\u548c\u773e\u591a\u65b0\u8208\u5e02\u5834\u3002 \u95dc\u65bc Organon Organon\uff08\u7d10\u7d04\u8b49\u5238\u4ea4\u6613\u6240\u4ee3\u78bc\uff1aOGN\uff09\u662f\u4e00\u5bb6\u5168\u7403\u5316\u91ab\u7642\u5065\u5eb7\u516c\u53f8\uff0c\u4f7f\u547d\u662f\u63d0\u4f9b\u6709\u6df1\u9060\u5f71\u97ff\u7684\u85e5\u7269\u8207\u89e3\u6c7a\u65b9\u6848\uff0c\u8b93\u4eba\u5011\u7684\u6bcf\u4e00\u5929\u66f4\u5065\u5eb7\u3002\u516c\u53f8\u5c08\u6ce8\u65bc\u89e3\u6c7a\u7368\u7279\uff0c\u91cd\u9ede\uff0c\u6216\u4ee5\u4e0d\u540c\u65b9\u5f0f\u5f71\u97ff\u5973\u6027\u7684\u5065\u5eb7\u9700\u6c42\uff0c\u63d0\u4f9b\u8d85\u904e70\u7a2e\u5973\u6027\u5065\u5eb7\u8207\u5e38\u898f\u85e5\u7269\u7684\u7522\u54c1\u7d44\u5408\uff0c\u5176\u4e2d\u5305\u62ec\u751f\u7269\u985e\u4f3c\u85e5\uff0c\u540c\u6642\u5728\u5168\u7403140\u591a\u500b\u5e02\u5834\u64f4\u5927\u57fa\u672c\u6cbb\u7642\u624b\u6bb5\u7684\u53ef\u53ca\u6027\u3002 \u516c\u53f8\u7e3d\u90e8\u4f4d\u65bc\u65b0\u6fa4\u897f\u5dde\u6fa4\u897f\u5e02\u3002Organon \u81f4\u529b\u65bc\u63a8\u52d5\u91ab\u7642\u7684\u53ef\u53ca\u6027\u3001\u53ef\u8ca0\u64d4\u6027\u8207\u5275\u65b0\u3002\u66f4\u591a\u4fe1\u606f\u8acb\u8a2a\u554f www.organon.com\uff0c\u4e26\u95dc\u6ce8\u6211\u5011\u7684 LinkedIn\u3001Instagram\u3001X\u3001YouTube\u3001TikTok \u548c Facebook\u3002 \u95dc\u65bc\u524d\u77bb\u6027\u8072\u660e\u7684\u6ce8\u610f\u4e8b\u9805 \u9664\u6b77\u53f2\u4fe1\u606f\u5916\uff0c\u672c\u65b0\u805e\u7a3f\u5305\u542b\u7684\u67d0\u4e9b\u9673\u8ff0\u548c\u62ab\u9732\u5c6c\u65bc1995\u5e74\u300a\u7f8e\u570b\u79c1\u4eba\u8b49\u5238\u8a34\u8a1f\u6539\u9769\u6cd5\u6848\u300b\u5b89\u5168\u6e2f\u689d\u6b3e\u6240\u6307\u7684\u300c\u524d\u77bb\u6027\u9673\u8ff0\u300d\uff0c\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\u6709\u95dcBILDYOS\u548cBILPREVDA\u696d\u52d9\u6a5f\u6703\u53ca\u5e02\u5834\u524d\u666f\u9810\u671f\u7684\u76f8\u95dc\u8868\u8ff0\u3002\u524d\u77bb\u6027\u9673\u8ff0\u53ef\u901a\u904e\u300c\u5c07\u6703\u300d\u3001\u300c\u6f5b\u5728\u300d\u3001\u300c\u76ee\u6a19\u300d\u3001\u300c\u63a2\u7d22\u300d\u3001\u300c\u6a5f\u6703\u300d\u3001\u300c\u9810\u671f\u300d\u3001\u300c\u672a\u4f86\u300d\u6216\u5177\u6709\u985e\u4f3c\u542b\u7fa9\u7684\u63aa\u8fad\u8b58\u5225\u3002\u9019\u4e9b\u524d\u77bb\u6027\u9673\u8ff0\u57fa\u65bcOrganon\u7ba1\u7406\u5c64\u7576\u524d\u7684\u8a08\u5283\u548c\u9810\u671f\uff0c\u4e26\u53d7\u5230\u91cd\u5927\u98a8\u96aa\u548c\u4e0d\u78ba\u5b9a\u6027\u7684\u5f71\u97ff\uff0c\u5982\u57fa\u672c\u5047\u5b9a\u4e0d\u6e96\u78ba\u6216\u98a8\u96aa\u6216\u4e0d\u78ba\u5b9a\u6027\u6210\u70ba\u73fe\u5be6\uff0c\u5be6\u969b\u7d50\u679c\u53ef\u80fd\u8207\u524d\u77bb\u6027\u8072\u660e\u4e2d\u6240\u8ff0\u7684\u7d50\u679c\u6709\u91cd\u5927\u5dee\u7570\u3002\u98a8\u96aa\u548c\u4e0d\u78ba\u5b9a\u6027\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\uff1a\u7121\u6cd5\u63a8\u5ee3 BILDYOS \u548c BILPREVDA\uff1b\u53ef\u80fd\u4e0d\u5229\u5f71\u97ff\u5176\u5e02\u5834\u9700\u6c42\u7684\u56e0\u7d20\uff08\u5305\u62ec\u8cbf\u6613\u4fdd\u8b77\u63aa\u65bd\u53ca\u9032\u51fa\u53e3\u8a31\u53ef\u8981\u6c42\u3001\u7f8e\u570b\u53ca\u5176\u4ed6\u570b\u5bb6\u6216\u5730\u5340\u5728\u806f\u90a6\u3001\u5dde\u53ca\u5730\u65b9\u5c64\u9762\u7684\u653f\u5e9c\u8cc7\u91d1\u5206\u914d\u8b8a\u5316\u2014\u2014\u5305\u62ec\u5206\u914d\u7d66 Organon \u5ba2\u6236\u53ca\u696d\u52d9\u5925\u4f34\u7684\u6642\u9593\u548c\u91d1\u984d\uff0c\u4ee5\u53ca\u7d93\u6fdf\u56e0\u7d20\uff09\uff1b\u4efb\u4f55\u4f9b\u61c9\u5546\u672a\u80fd\u6309\u7d04\u63d0\u4f9b\u7269\u8cea\u3001\u6750\u6599\u6216\u670d\u52d9\uff1b\u4f9b\u61c9\u3001\u751f\u7522\u3001\u5305\u88dd\u548c\u904b\u71df\u6210\u672c\u7684\u589e\u52a0\uff1b\u5168\u7403\u7bc4\u570d\u5167\u7684\u5b9a\u50f9\u58d3\u529b\uff0c\u5305\u62ec\u91ab\u7642\u4fdd\u96aa\u7ba1\u7406\u7d44\u7e54\u7684\u898f\u5247\u8207\u505a\u6cd5\u3001\u53f8\u6cd5\u5224\u6c7a\u4ee5\u53ca\u8207\u91ab\u4fdd\uff08Medicare\uff09\u3001\u91ab\u7642\u88dc\u52a9\uff08Medicaid\uff09\u53ca\u91ab\u7642\u6539\u9769\u76f8\u95dc\u7684\u653f\u5e9c\u6cd5\u5f8b\u6cd5\u898f\uff0c\u4ee5\u53ca\u85e5\u54c1\u88dc\u511f\u8207\u5b9a\u50f9\u7e3d\u9ad4\u74b0\u5883\uff1b\u751f\u7522\u56f0\u96e3\u6216\u5ef6\u9072\uff1b\u7f8e\u570b FDA \u6216\u5176\u4ed6\u653f\u5e9c\u6a5f\u69cb\u7684\u91cd\u7d44\u6216\u5176\u4ed6\u5e72\u64fe\uff1b\u7642\u6548\u3001\u5b89\u5168\u6027\u6216\u5176\u4ed6\u8cea\u91cf\u65b9\u9762\u7684\u9867\u616e\uff1b\u4ee5\u53ca\u7b2c\u4e09\u65b9\u672a\u4f86\u7684\u884c\u52d5\uff0c\u5305\u62ec\u5ba2\u6236\u95dc\u4fc2\u7684\u91cd\u5927\u8b8a\u5316\uff0c\u6216\u91ab\u7642\u7522\u54c1\u8207\u670d\u52d9\u8cfc\u8cb7\u8005\u7684\u884c\u70ba\u8207\u6d88\u8cbb\u6a21\u5f0f\u7684\u8b8a\u5316\uff0c\u4f8b\u5982\u63a8\u9072\u91ab\u7642\u7a0b\u5e8f\u3001\u9650\u5236\u8655\u65b9\u85e5\u4f7f\u7528\u3001\u6e1b\u5c11\u5c31\u8a3a\u983b\u7387\uff0c\u4ee5\u53ca\u653e\u68c4\u91ab\u7642\u4fdd\u96aa\u8986\u84cb\u7b49\u3002Organon \u6c92\u6709\u7fa9\u52d9\u56e0\u65b0\u4fe1\u606f\u3001\u672a\u4f86\u4e8b\u4ef6\u6216\u5176\u4ed6\u539f\u56e0\u800c\u516c\u958b\u66f4\u65b0\u4efb\u4f55\u524d\u77bb\u6027\u8072\u660e\u3002\u5c0e\u81f4\u7d50\u679c\u8207\u524d\u77bb\u6027\u8072\u660e\u6240\u8ff0\u5b58\u5728\u91cd\u5927\u5dee\u7570\u7684\u5176\u4ed6\u56e0\u7d20\uff0c\u53ef\u898b\u65bc Organon \u5411\u7f8e\u570b\u8b49\u5238\u4ea4\u6613\u59d4\u54e1\u6703\uff08SEC\uff09\u63d0\u4ea4\u7684\u6587\u4ef6\uff0c\u5305\u62ec Organon \u6700\u65b0\u7684\u5e74\u5ea6\u5831\u544a Form 10-K \u53ca\u5176\u5f8c\u7e8c\u6587\u4ef6\uff08\u5305\u62ec\u622a\u81f3 2025 \u5e74 6 \u6708 30 \u65e5\u5b63\u5ea6\u7684\u5b63\u5ea6\u5831\u544a Form 10-Q\uff09\uff0c\u53ef\u5728 SEC \u7db2\u7ad9 (www.sec.gov) \u67e5\u95b1\u3002\u6240\u63d0\u4f9b\u7684\u53c3\u8003\u8207\u7db2\u7ad9\u93c8\u63a5\u50c5\u70ba\u65b9\u4fbf\u8d77\u898b\uff0c\u4efb\u4f55\u6b64\u985e\u7db2\u7ad9\u6240\u8f09\u4fe1\u606f\u5747\u4e0d\u69cb\u6210\u672c\u65b0\u805e\u7a3f\u7684\u4e00\u90e8\u5206\uff0c\u4e5f\u4e0d\u88ab\u8996\u70ba\u5f15\u7528\u4f75\u5165\u672c\u65b0\u805e\u7a3f\u3002Organon \u5c0d\u7b2c\u4e09\u65b9\u7db2\u7ad9\u5167\u5bb9\u4e0d\u627f\u64d4\u8cac\u4efb\u3002 PROLIA \u548c XGEVA \u70ba\u5b89\u9032\u516c\u53f8\uff08Amgen, Inc.\uff09\u5728\u6b50\u6d32\u8a3b\u518a\u7684\u5546\u6a19\uff1bOrganon \u8207\u8a72\u5546\u6a19\u6301\u6709\u4eba\u4e0d\u5b58\u5728\u4efb\u4f55\u95dc\u806f\u3002<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_generate-full-width-content":"","spay_email":"","footnotes":""},"categories":[1],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>\u518d\u4e0b\u4e00\u57ce \u5fa9\u5b8f\u6f22\u9716\u8207Organon\u5171\u540c\u5ba3\u4f48\u5730\u8212\u55ae\u6297BILDYOS\u00ae\u548cBILPREVDA\u00ae\u7372\u6b50\u76df\u6279\u51c6\u4e0a\u5e02 - \u9999\u6e2f\u7279\u8a31\u7d93\u71df<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.franchise.com.hk\/en\/%e5%86%8d%e4%b8%8b%e4%b8%80%e5%9f%8e-%e5%be%a9%e5%ae%8f%e6%bc%a2%e9%9c%96%e8%88%87organon%e5%85%b1%e5%90%8c%e5%ae%a3%e4%bd%88%e5%9c%b0%e8%88%92%e5%96%ae%e6%8a%97bildyos%e5%92%8cbilprevda\/28130\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u518d\u4e0b\u4e00\u57ce \u5fa9\u5b8f\u6f22\u9716\u8207Organon\u5171\u540c\u5ba3\u4f48\u5730\u8212\u55ae\u6297BILDYOS\u00ae\u548cBILPREVDA\u00ae\u7372\u6b50\u76df\u6279\u51c6\u4e0a\u5e02 - \u9999\u6e2f\u7279\u8a31\u7d93\u71df\" \/>\n<meta property=\"og:description\" content=\"\u4e0a\u6d77\u548c\u65b0\u6fa4\u897f\u5dde\u6fa4\u897f\u5e022025\u5e749\u670819\u65e5 \/\u7f8e\u901a\u793e\/ &#8212; \u5fa9\u5b8f\u6f22\u9716\uff082696.HK\uff09\u8207Organon\uff08\u7d10\u4ea4\u6240\u4ee3\u78bc\uff1aOGN\uff09\u4eca\u65e5\u806f\u5408\u5ba3\u4f48\uff0c\u6b50\u76df\u59d4\u54e1\u6703\uff08EC\uff09\u5df2\u6279\u51c6\u5730\u8212\u55ae\u6297\u6ce8\u5c04\u6db2\uff0860 mg\/mL\uff09BILDYOS\u00ae\uff08denosumab\uff09\u548c\u5730\u8212\u55ae\u6297\u6ce8\u5c04\u6db2\uff08120mg\/1.7mL\uff09BILPREVDA\u00ae\uff08denosumab\uff09\u7684\u4e0a\u5e02\u8a31\u53ef\uff0c\u5169\u6b3e\u7522\u54c1\u5206\u5225\u70baPROLIA\u00ae\uff08\u5730\u8212\u55ae\u6297\uff09\u548cXGEVA\u00ae\uff08\u5730\u8212\u55ae\u6297\uff09\u7684\u751f\u7269\u985e\u4f3c\u85e5\uff0c\u8986\u84cb\u539f\u7814\u7522\u54c1\u5728\u6b50\u76df\u5df2\u7372\u6279\u7684\u6240\u6709\u9069\u61c9\u75c7[1,2]\u3002 Organon\u570b\u969b\u5546\u696d\u8ca0\u8cac\u4ebaNico Van Hoecke\u8868\u793a\uff1a\u300cBILDYOS\u548cBILPREVDA\u7684\u6b50\u76df\u7372\u6279\uff0c\u6a19\u8a8c\u8457\u6211\u5011\u5728\u70ba\u6578\u767e\u842c\u6b50\u6d32\u60a3\u8005\uff0c\u7279\u5225\u662f\u53d7\u9aa8\u8cea\u758f\u9b06\u75c7\u5f71\u97ff\u6bd4\u4f8b\u66f4\u9ad8\u7684\u5973\u6027\uff0c\u64f4\u5927\u95dc\u9375\u9aa8\u9abc\u5065\u5eb7\u6cbb\u7642\u53ef\u53ca\u6027\u65b9\u9762\u9081\u51fa\u4e86\u95dc\u9375\u4e00\u6b65[3,4]\u3002\u9019\u4e9b\u751f\u7269\u985e\u4f3c\u85e5\u53ef\u70ba\u5305\u62ec\u9aa8\u8cea\u758f\u9b06\u75c7\u5728\u5167\u7684\u9aa8\u8cea\u6d41\u5931\u76f8\u95dc\u7684\u591a\u500b\u6cbb\u7642\u9818\u57df\u63d0\u4f9b\u66f4\u591a\u9078\u64c7\uff0c\u9ad4\u73fe\u4e86Organon\u901a\u904e\u63d0\u5347\u85e5\u7269\u53ef\u53ca\u6027\u4f86\u63a8\u52d5\u5973\u6027\u5065\u5eb7\u7684\u627f\u8afe\u3002\u5728\u7f8e\u570b\u7372\u6279\u4e4b\u5f8c\uff0c\u9019\u6b21\u7684\u6b50\u76df\u6279\u51c6\u4e0d\u50c5\u62d3\u5c55\u4e86\u5169\u6b3e\u751f\u7269\u985e\u4f3c\u85e5\u7684\u5168\u7403\u53ef\u53ca\u7bc4\u570d\uff0c\u540c\u6642\u4e5f\u652f\u6301\u4e86\u6b50\u6d32\u91ab\u7642\u9ad4\u7cfb\u7684\u53ef\u6301\u7e8c\u767c\u5c55[5,6]\u3002\u300d \u5fa9\u5b8f\u6f22\u9716\u9996\u5e2d\u5546\u52d9\u767c\u5c55\u5b98\u517c\u9ad8\u7d1a\u526f\u7e3d\u88c1\u66f9\u5e73\u8868\u793a\uff1a\u300c\u6b64\u6b21\u7372\u6279\u662f\u5fa9\u5b8f\u6f22\u9716\u8207Organon\u5f37\u5f37\u806f\u5408\u3001\u5171\u540c\u6eff\u8db3\u6b50\u6d32\u60a3\u8005\u548c\u91ab\u7642\u7cfb\u7d71\u9700\u6c42\u7684\u53c8\u4e00\u91cd\u8981\u6210\u679c\u3002\u6191\u501f\u5c0d\u79d1\u5b78\u5353\u8d8a\u8207\u7522\u54c1\u8cea\u91cf\u7684\u59cb\u7d42\u5805\u5b88\uff0c\u6211\u5011\u5728\u7f8e\u570b\u7372\u6279\u7684\u57fa\u790e\u4e0a\u4e0d\u65b7\u524d\u884c\uff0c\u5c07\u9019\u4e9b\u751f\u7269\u985e\u4f3c\u85e5\u6cbb\u7642\u65b9\u6848\u5e36\u7d66\u5168\u7403\u66f4\u591a\u6709\u9700\u8981\u7684\u60a3\u8005[6]\u3002\u300d BILDYOS\u9069\u7528\u6cbb\u7642\u9aa8\u6298\u9ad8\u98a8\u96aa\u7684\u7d55\u7d93\u5f8c\u5a66\u5973\u53ca\u7537\u6027\u7684\u9aa8\u8cea\u758f\u9b06\u75c7\uff1b\u9aa8\u6298\u9ad8\u98a8\u96aa\u7684\u524d\u5217\u817a\u764c\u7537\u6027\u56e0\u6fc0\u7d20\u525d\u596a\u5c0e\u81f4\u7684\u9aa8\u8cea\u6d41\u5931\uff1b\u4ee5\u53ca\u9aa8\u6298\u9ad8\u98a8\u96aa\u6210\u5e74\u60a3\u8005\u56e0\u9577\u671f\u5168\u8eab\u7cd6\u76ae\u8cea\u6fc0\u7d20\u6cbb\u7642\u5c0e\u81f4\u7684\u9aa8\u8cea\u6d41\u5931\u3002BILPREVDA\u9069\u7528\u65bc\u9810\u9632\u7d2f\u53ca\u9aa8\u9abc\u7684\u665a\u671f\u60e1\u6027\u816b\u7624\u6210\u4eba\u7684\u9aa8\u76f8\u95dc\u4e8b\u4ef6\uff0c\u4ee5\u53ca\u6cbb\u7642\u4e0d\u53ef\u624b\u8853\u5207\u9664\u6216\u624b\u8853\u5207\u9664\u5f8c\u53ef\u80fd\u5c0e\u81f4\u56b4\u91cd\u529f\u80fd\u969c\u7919\u7684\u9aa8\u9245\u7d30\u80de\u7624\u60a3\u8005\uff0c\u5305\u62ec\u6210\u4eba\u548c\u9aa8\u9abc\u767c\u80b2\u6210\u719f\u7684\u9752\u5c11\u5e74\u60a3\u8005\u3002 BILDYOS\u548cBILPREVDA\u7684\u7372\u6279\u662f\u57fa\u65bc\u4e00\u6574\u5957\u5168\u9762\u6578\u64da\u7684\u5be9\u67e5\uff0c\u5176\u4e2d\u5305\u62ec\u7d50\u69cb\u8207\u529f\u80fd\u5206\u6790\u6578\u64da\u3001\u81e8\u5e8a\u85e5\u4ee3\u52d5\u529b\u5b78\u6578\u64da\uff0c\u4ee5\u53ca\u4e00\u9805\u81e8\u5e8a\u5c0d\u6bd4\u7814\u7a76\u3002\u7814\u7a76\u8868\u660e\uff0cBILDYOS\u548cBILPREVDA\u5728\u7d50\u69cb\u3001\u751f\u7269\u6d3b\u6027\u4ee5\u53ca\u7642\u6548\u3001\u5b89\u5168\u6027\u548c\u514d\u75ab\u539f\u6027\u7279\u5fb5\uff08\u86cb\u767d\u548c\u5176\u4ed6\u751f\u7269\u85e5\u7269\u8a98\u767c\u514d\u75ab\u61c9\u7b54\u6216\u514d\u75ab\u76f8\u95dc\u4e8b\u4ef6\u7684\u80fd\u529b\uff09\u65b9\u9762\u8207\u6b50\u76df\u5df2\u6279\u51c6\u7684\u53e6\u4e00\u7a2e\u751f\u7269\u85e5\uff08\u5373\u300c\u539f\u7814\u7522\u54c1\u300d\uff09\u9ad8\u5ea6\u76f8\u4f3c\u3002 2022\u5e74\uff0c\u5fa9\u5b8f\u6f22\u9716\u8207Organon\u7c3d\u8a02\u8a31\u53ef\u8207\u4f9b\u61c9\u5354\u8b70\uff0c\u6388\u4e88Organon\u5c0d\u5305\u62ecBILDYOS\u548cBILPREVDA\u5728\u5167\u7684\u591a\u500b\u751f\u7269\u985e\u4f3c\u85e5\u5728\u9664\u4e2d\u570b\u4ee5\u5916\u7684\u5168\u7403\u5340\u57df\u7684\u7368\u5bb6\u5546\u696d\u5316\u6b0a\u76ca[7]\u3002 \u53c3\u8003\u6587\u737b\uff1a PROLIA. Product Information. Amgen; 2025. XGEVA. Product Information. Amgen; 2025. J. Kanis, Norton, N., Harvey, N., et al. SCOPE 2021: a new scorecard for osteoporosis in Europe. Archives of Osteoporosis. (2021) 16:82. Accessed September 15, 2025. Available at https:\/\/www.osteoporosis.foundation\/sites\/iofbonehealth\/files\/202106\/Kanis2021_Article_SCOPE2021ANewScorecardForOsteo.pdf Biosimilar medicines: overview. European Medicines Agency (EMA). April 2, 2025. Accessed September 15, 2025. https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/biosimilar-medicines-overview.\u00a0 Troein P, Max Newton, Stoddart K, Travaglio M, Aurelio Arias. The impact of biosimilar competition in Europe. 2025. Accessed September 15, 2025. https:\/\/www.iqvia.com\/-\/media\/iqvia\/pdfs\/library\/white-papers\/the-impact-of-biosimilar-competition-in-europe-2024.pdf.\u00a0 US Food and Drug Administration (FDA) Approves Henlius and Organon&#8217;s BILDYOS\u00ae (denosumab-nxxp) and BILPREVDA\u00ae (denosumab-nxxp), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively. Organon. Published September 2, 2025. Accessed September 15, 2025.\u00a0https:\/\/www.organon.com\/news\/us-food-and-drug-administration-fda-approves-henlius-and-organons-bildyos-denosumab-nxxp-and-bilprevda-denosumab-nxxp-biosimilars-to-prolia-denosumab-and-xgeva-denosumab\/ Organon Enters into Global License Agreement to Commercialize Henlius&#8217; Investigational Perjeta\u00a0\u00ae(Pertuzumab) and Prolia \u00ae\/Xgeva \u00ae(Denosumab) Biosimilar Candidates. Organon. June 13, 2022. Accessed September 15, 2025. https:\/\/www.organon.com\/news\/organon-enters-into-global-license-agreement-to-commercialize-henlius-investigational-perjeta-pertuzumab-and-prolia-xgeva-denosumab-biosimilar-candidates\/\u00a0 \u95dc\u65bc\u5fa9\u5b8f\u6f22\u9716 \u5fa9\u5b8f\u6f22\u9716\uff082696.HK\uff09\u662f\u4e00\u5bb6\u570b\u969b\u5316\u7684\u5275\u65b0\u751f\u7269\u88fd\u85e5\u516c\u53f8\uff0c\u81f4\u529b\u65bc\u70ba\u5168\u7403\u60a3\u8005\u63d0\u4f9b\u53ef\u8ca0\u64d4\u7684\u9ad8\u54c1\u8cea\u751f\u7269\u85e5\uff0c\u7522\u54c1\u8986\u84cb\u816b\u7624\u3001\u81ea\u8eab\u514d\u75ab\u75be\u75c5\u3001\u773c\u79d1\u75be\u75c5\u7b49\u9818\u57df\uff0c\u5df2\u5728\u5168\u7403\u7372\u6279\u4e0a\u5e029\u6b3e\u7522\u54c1\uff0c4\u500b\u4e0a\u5e02\u7533\u8acb\u5206\u5225\u7372\u4e2d\u570b\u85e5\u76e3\u5c40\u3001\u7f8e\u570bFDA\u548c\u6b50\u76dfEMA\u53d7\u7406\u3002\u81ea2010\u5e74\u6210\u7acb\u4ee5\u4f86\uff0c\u5fa9\u5b8f\u6f22\u9716\u5df2\u5efa\u6210\u4e00\u9ad4\u5316\u751f\u7269\u88fd\u85e5\u5e73\u53f0\uff0c\u9ad8\u6548\u53ca\u5275\u65b0\u7684\u81ea\u4e3b\u6838\u5fc3\u80fd\u529b\u8cab\u7a7f\u7814\u767c\u3001\u751f\u7522\u53ca\u5546\u696d\u904b\u71df\u5168\u7522\u696d\u93c8\u3002\u516c\u53f8\u5df2\u5efa\u7acb\u5b8c\u5584\u9ad8\u6548\u7684\u5168\u7403\u5275\u65b0\u4e2d\u5fc3\uff0c\u6309\u7167\u570b\u969b\u85e5\u54c1\u751f\u7522\u8cea\u91cf\u7ba1\u7406\u898f\u7bc4\uff08GMP\uff09\u6a19\u6e96\u9032\u884c\u751f\u7522\u548c\u8cea\u91cf\u7ba1\u63a7\uff0c\u4e0d\u65b7\u592f\u5be6\u4e00\u9ad4\u5316\u7d9c\u5408\u751f\u7522\u5e73\u53f0\uff0c\u5176\u4e2d\uff0c\u516c\u53f8\u5546\u696d\u5316\u751f\u7522\u57fa\u5730\u5df2\u76f8\u7e7c\u7372\u5f97\u4e2d\u570b\u3001\u6b50\u76df\u548c\u7f8e\u570bGMP\u8a8d\u8b49\u3002 \u5fa9\u5b8f\u6f22\u9716\u524d\u77bb\u6027\u4f48\u5c40\u4e86\u4e00\u500b\u591a\u5143\u5316\u3001\u9ad8\u8cea\u91cf\u7684\u7522\u54c1\u7ba1\u7dda\uff0c\u6db5\u84cb\u7d0450\u500b\u5206\u5b50\uff0c\u4e26\u5168\u9762\u63a8\u9032\u57fa\u65bc\u81ea\u6709\u6297PD-1\u55ae\u6297H\u85e5\u6f22\u65af\u72c0\u00ae\u7684\u816b\u7624\u514d\u75ab\u806f\u5408\u7642\u6cd5\u3002\u622a\u81f3\u76ee\u524d\uff0c\u516c\u53f8\u5df2\u7372\u6279\u4e0a\u5e02\u7522\u54c1\u5305\u62ec\u5168\u7403\u9996\u500b\u7372\u6279\u4e00\u7dda\u6cbb\u7642\u5c0f\u7d30\u80de\u80ba\u764c\u7684\u6297PD-1\u55ae\u6297\u6f22\u65af\u72c0\u00ae\uff08\u65af\u9b6f\u5229\u55ae\u6297\uff0c\u6b50\u6d32\u5546\u54c1\u540d\uff1aHetronifly\u00ae\uff09\u3001\u81ea\u4e3b\u7814\u767c\u7684\u4e2d\u7f8e\u6b50\u4e09\u5730\u7372\u6279\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5\u6f22\u66f2\u512a\u00ae\uff08\u66f2\u59a5\u73e0\u55ae\u6297\uff0c\u7f8e\u570b\u5546\u54c1\u540d\uff1aHERCESSI\u2122\uff0c\u6b50\u6d32\u5546\u54c1\u540d\uff1aZercepac\u00ae\uff09\u3001\u570b\u5167\u9996\u500b\u751f\u7269\u985e\u4f3c\u85e5\u6f22\u5229\u5eb7\u00ae\uff08\u5229\u59a5\u6614\u55ae\u6297\uff09\u3001\u4ee5\u53ca\u5730\u8212\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5Bildyos\u00ae\u548cBilprevda\u00ae\u3002\u516c\u53f8\u4ea6\u540c\u6b65\u5c3119\u500b\u7522\u54c1\u5728\u5168\u7403\u7bc4\u570d\u5167\u958b\u5c5530\u591a\u9805\u81e8\u5e8a\u8a66\u9a57\uff0c\u5c0d\u5916\u6388\u6b0a\u5168\u9762\u8986\u84cb\u6b50\u7f8e\u4e3b\u6d41\u751f\u7269\u85e5\u5e02\u5834\u548c\u773e\u591a\u65b0\u8208\u5e02\u5834\u3002 \u95dc\u65bc Organon Organon\uff08\u7d10\u7d04\u8b49\u5238\u4ea4\u6613\u6240\u4ee3\u78bc\uff1aOGN\uff09\u662f\u4e00\u5bb6\u5168\u7403\u5316\u91ab\u7642\u5065\u5eb7\u516c\u53f8\uff0c\u4f7f\u547d\u662f\u63d0\u4f9b\u6709\u6df1\u9060\u5f71\u97ff\u7684\u85e5\u7269\u8207\u89e3\u6c7a\u65b9\u6848\uff0c\u8b93\u4eba\u5011\u7684\u6bcf\u4e00\u5929\u66f4\u5065\u5eb7\u3002\u516c\u53f8\u5c08\u6ce8\u65bc\u89e3\u6c7a\u7368\u7279\uff0c\u91cd\u9ede\uff0c\u6216\u4ee5\u4e0d\u540c\u65b9\u5f0f\u5f71\u97ff\u5973\u6027\u7684\u5065\u5eb7\u9700\u6c42\uff0c\u63d0\u4f9b\u8d85\u904e70\u7a2e\u5973\u6027\u5065\u5eb7\u8207\u5e38\u898f\u85e5\u7269\u7684\u7522\u54c1\u7d44\u5408\uff0c\u5176\u4e2d\u5305\u62ec\u751f\u7269\u985e\u4f3c\u85e5\uff0c\u540c\u6642\u5728\u5168\u7403140\u591a\u500b\u5e02\u5834\u64f4\u5927\u57fa\u672c\u6cbb\u7642\u624b\u6bb5\u7684\u53ef\u53ca\u6027\u3002 \u516c\u53f8\u7e3d\u90e8\u4f4d\u65bc\u65b0\u6fa4\u897f\u5dde\u6fa4\u897f\u5e02\u3002Organon \u81f4\u529b\u65bc\u63a8\u52d5\u91ab\u7642\u7684\u53ef\u53ca\u6027\u3001\u53ef\u8ca0\u64d4\u6027\u8207\u5275\u65b0\u3002\u66f4\u591a\u4fe1\u606f\u8acb\u8a2a\u554f www.organon.com\uff0c\u4e26\u95dc\u6ce8\u6211\u5011\u7684 LinkedIn\u3001Instagram\u3001X\u3001YouTube\u3001TikTok \u548c Facebook\u3002 \u95dc\u65bc\u524d\u77bb\u6027\u8072\u660e\u7684\u6ce8\u610f\u4e8b\u9805 \u9664\u6b77\u53f2\u4fe1\u606f\u5916\uff0c\u672c\u65b0\u805e\u7a3f\u5305\u542b\u7684\u67d0\u4e9b\u9673\u8ff0\u548c\u62ab\u9732\u5c6c\u65bc1995\u5e74\u300a\u7f8e\u570b\u79c1\u4eba\u8b49\u5238\u8a34\u8a1f\u6539\u9769\u6cd5\u6848\u300b\u5b89\u5168\u6e2f\u689d\u6b3e\u6240\u6307\u7684\u300c\u524d\u77bb\u6027\u9673\u8ff0\u300d\uff0c\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\u6709\u95dcBILDYOS\u548cBILPREVDA\u696d\u52d9\u6a5f\u6703\u53ca\u5e02\u5834\u524d\u666f\u9810\u671f\u7684\u76f8\u95dc\u8868\u8ff0\u3002\u524d\u77bb\u6027\u9673\u8ff0\u53ef\u901a\u904e\u300c\u5c07\u6703\u300d\u3001\u300c\u6f5b\u5728\u300d\u3001\u300c\u76ee\u6a19\u300d\u3001\u300c\u63a2\u7d22\u300d\u3001\u300c\u6a5f\u6703\u300d\u3001\u300c\u9810\u671f\u300d\u3001\u300c\u672a\u4f86\u300d\u6216\u5177\u6709\u985e\u4f3c\u542b\u7fa9\u7684\u63aa\u8fad\u8b58\u5225\u3002\u9019\u4e9b\u524d\u77bb\u6027\u9673\u8ff0\u57fa\u65bcOrganon\u7ba1\u7406\u5c64\u7576\u524d\u7684\u8a08\u5283\u548c\u9810\u671f\uff0c\u4e26\u53d7\u5230\u91cd\u5927\u98a8\u96aa\u548c\u4e0d\u78ba\u5b9a\u6027\u7684\u5f71\u97ff\uff0c\u5982\u57fa\u672c\u5047\u5b9a\u4e0d\u6e96\u78ba\u6216\u98a8\u96aa\u6216\u4e0d\u78ba\u5b9a\u6027\u6210\u70ba\u73fe\u5be6\uff0c\u5be6\u969b\u7d50\u679c\u53ef\u80fd\u8207\u524d\u77bb\u6027\u8072\u660e\u4e2d\u6240\u8ff0\u7684\u7d50\u679c\u6709\u91cd\u5927\u5dee\u7570\u3002\u98a8\u96aa\u548c\u4e0d\u78ba\u5b9a\u6027\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\uff1a\u7121\u6cd5\u63a8\u5ee3 BILDYOS \u548c BILPREVDA\uff1b\u53ef\u80fd\u4e0d\u5229\u5f71\u97ff\u5176\u5e02\u5834\u9700\u6c42\u7684\u56e0\u7d20\uff08\u5305\u62ec\u8cbf\u6613\u4fdd\u8b77\u63aa\u65bd\u53ca\u9032\u51fa\u53e3\u8a31\u53ef\u8981\u6c42\u3001\u7f8e\u570b\u53ca\u5176\u4ed6\u570b\u5bb6\u6216\u5730\u5340\u5728\u806f\u90a6\u3001\u5dde\u53ca\u5730\u65b9\u5c64\u9762\u7684\u653f\u5e9c\u8cc7\u91d1\u5206\u914d\u8b8a\u5316\u2014\u2014\u5305\u62ec\u5206\u914d\u7d66 Organon \u5ba2\u6236\u53ca\u696d\u52d9\u5925\u4f34\u7684\u6642\u9593\u548c\u91d1\u984d\uff0c\u4ee5\u53ca\u7d93\u6fdf\u56e0\u7d20\uff09\uff1b\u4efb\u4f55\u4f9b\u61c9\u5546\u672a\u80fd\u6309\u7d04\u63d0\u4f9b\u7269\u8cea\u3001\u6750\u6599\u6216\u670d\u52d9\uff1b\u4f9b\u61c9\u3001\u751f\u7522\u3001\u5305\u88dd\u548c\u904b\u71df\u6210\u672c\u7684\u589e\u52a0\uff1b\u5168\u7403\u7bc4\u570d\u5167\u7684\u5b9a\u50f9\u58d3\u529b\uff0c\u5305\u62ec\u91ab\u7642\u4fdd\u96aa\u7ba1\u7406\u7d44\u7e54\u7684\u898f\u5247\u8207\u505a\u6cd5\u3001\u53f8\u6cd5\u5224\u6c7a\u4ee5\u53ca\u8207\u91ab\u4fdd\uff08Medicare\uff09\u3001\u91ab\u7642\u88dc\u52a9\uff08Medicaid\uff09\u53ca\u91ab\u7642\u6539\u9769\u76f8\u95dc\u7684\u653f\u5e9c\u6cd5\u5f8b\u6cd5\u898f\uff0c\u4ee5\u53ca\u85e5\u54c1\u88dc\u511f\u8207\u5b9a\u50f9\u7e3d\u9ad4\u74b0\u5883\uff1b\u751f\u7522\u56f0\u96e3\u6216\u5ef6\u9072\uff1b\u7f8e\u570b FDA \u6216\u5176\u4ed6\u653f\u5e9c\u6a5f\u69cb\u7684\u91cd\u7d44\u6216\u5176\u4ed6\u5e72\u64fe\uff1b\u7642\u6548\u3001\u5b89\u5168\u6027\u6216\u5176\u4ed6\u8cea\u91cf\u65b9\u9762\u7684\u9867\u616e\uff1b\u4ee5\u53ca\u7b2c\u4e09\u65b9\u672a\u4f86\u7684\u884c\u52d5\uff0c\u5305\u62ec\u5ba2\u6236\u95dc\u4fc2\u7684\u91cd\u5927\u8b8a\u5316\uff0c\u6216\u91ab\u7642\u7522\u54c1\u8207\u670d\u52d9\u8cfc\u8cb7\u8005\u7684\u884c\u70ba\u8207\u6d88\u8cbb\u6a21\u5f0f\u7684\u8b8a\u5316\uff0c\u4f8b\u5982\u63a8\u9072\u91ab\u7642\u7a0b\u5e8f\u3001\u9650\u5236\u8655\u65b9\u85e5\u4f7f\u7528\u3001\u6e1b\u5c11\u5c31\u8a3a\u983b\u7387\uff0c\u4ee5\u53ca\u653e\u68c4\u91ab\u7642\u4fdd\u96aa\u8986\u84cb\u7b49\u3002Organon \u6c92\u6709\u7fa9\u52d9\u56e0\u65b0\u4fe1\u606f\u3001\u672a\u4f86\u4e8b\u4ef6\u6216\u5176\u4ed6\u539f\u56e0\u800c\u516c\u958b\u66f4\u65b0\u4efb\u4f55\u524d\u77bb\u6027\u8072\u660e\u3002\u5c0e\u81f4\u7d50\u679c\u8207\u524d\u77bb\u6027\u8072\u660e\u6240\u8ff0\u5b58\u5728\u91cd\u5927\u5dee\u7570\u7684\u5176\u4ed6\u56e0\u7d20\uff0c\u53ef\u898b\u65bc Organon \u5411\u7f8e\u570b\u8b49\u5238\u4ea4\u6613\u59d4\u54e1\u6703\uff08SEC\uff09\u63d0\u4ea4\u7684\u6587\u4ef6\uff0c\u5305\u62ec Organon \u6700\u65b0\u7684\u5e74\u5ea6\u5831\u544a Form 10-K \u53ca\u5176\u5f8c\u7e8c\u6587\u4ef6\uff08\u5305\u62ec\u622a\u81f3 2025 \u5e74 6 \u6708 30 \u65e5\u5b63\u5ea6\u7684\u5b63\u5ea6\u5831\u544a Form 10-Q\uff09\uff0c\u53ef\u5728 SEC \u7db2\u7ad9 (www.sec.gov) \u67e5\u95b1\u3002\u6240\u63d0\u4f9b\u7684\u53c3\u8003\u8207\u7db2\u7ad9\u93c8\u63a5\u50c5\u70ba\u65b9\u4fbf\u8d77\u898b\uff0c\u4efb\u4f55\u6b64\u985e\u7db2\u7ad9\u6240\u8f09\u4fe1\u606f\u5747\u4e0d\u69cb\u6210\u672c\u65b0\u805e\u7a3f\u7684\u4e00\u90e8\u5206\uff0c\u4e5f\u4e0d\u88ab\u8996\u70ba\u5f15\u7528\u4f75\u5165\u672c\u65b0\u805e\u7a3f\u3002Organon \u5c0d\u7b2c\u4e09\u65b9\u7db2\u7ad9\u5167\u5bb9\u4e0d\u627f\u64d4\u8cac\u4efb\u3002 PROLIA \u548c XGEVA \u70ba\u5b89\u9032\u516c\u53f8\uff08Amgen, Inc.\uff09\u5728\u6b50\u6d32\u8a3b\u518a\u7684\u5546\u6a19\uff1bOrganon \u8207\u8a72\u5546\u6a19\u6301\u6709\u4eba\u4e0d\u5b58\u5728\u4efb\u4f55\u95dc\u806f\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.franchise.com.hk\/en\/%e5%86%8d%e4%b8%8b%e4%b8%80%e5%9f%8e-%e5%be%a9%e5%ae%8f%e6%bc%a2%e9%9c%96%e8%88%87organon%e5%85%b1%e5%90%8c%e5%ae%a3%e4%bd%88%e5%9c%b0%e8%88%92%e5%96%ae%e6%8a%97bildyos%e5%92%8cbilprevda\/28130\" \/>\n<meta property=\"og:site_name\" content=\"\u9999\u6e2f\u7279\u8a31\u7d93\u71df\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-19T04:32:00+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.franchise.com.hk\/en\/%e5%86%8d%e4%b8%8b%e4%b8%80%e5%9f%8e-%e5%be%a9%e5%ae%8f%e6%bc%a2%e9%9c%96%e8%88%87organon%e5%85%b1%e5%90%8c%e5%ae%a3%e4%bd%88%e5%9c%b0%e8%88%92%e5%96%ae%e6%8a%97bildyos%e5%92%8cbilprevda\/28130#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.franchise.com.hk\/en\/%e5%86%8d%e4%b8%8b%e4%b8%80%e5%9f%8e-%e5%be%a9%e5%ae%8f%e6%bc%a2%e9%9c%96%e8%88%87organon%e5%85%b1%e5%90%8c%e5%ae%a3%e4%bd%88%e5%9c%b0%e8%88%92%e5%96%ae%e6%8a%97bildyos%e5%92%8cbilprevda\/28130\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"\u518d\u4e0b\u4e00\u57ce \u5fa9\u5b8f\u6f22\u9716\u8207Organon\u5171\u540c\u5ba3\u4f48\u5730\u8212\u55ae\u6297BILDYOS\u00ae\u548cBILPREVDA\u00ae\u7372\u6b50\u76df\u6279\u51c6\u4e0a\u5e02\",\"datePublished\":\"2025-09-19T04:32:00+00:00\",\"dateModified\":\"2025-09-19T04:32:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.franchise.com.hk\/en\/%e5%86%8d%e4%b8%8b%e4%b8%80%e5%9f%8e-%e5%be%a9%e5%ae%8f%e6%bc%a2%e9%9c%96%e8%88%87organon%e5%85%b1%e5%90%8c%e5%ae%a3%e4%bd%88%e5%9c%b0%e8%88%92%e5%96%ae%e6%8a%97bildyos%e5%92%8cbilprevda\/28130\"},\"wordCount\":243,\"publisher\":{\"@id\":\"https:\/\/www.franchise.com.hk\/en#organization\"},\"articleSection\":[\"\u672a\u5206\u985e\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.franchise.com.hk\/en\/%e5%86%8d%e4%b8%8b%e4%b8%80%e5%9f%8e-%e5%be%a9%e5%ae%8f%e6%bc%a2%e9%9c%96%e8%88%87organon%e5%85%b1%e5%90%8c%e5%ae%a3%e4%bd%88%e5%9c%b0%e8%88%92%e5%96%ae%e6%8a%97bildyos%e5%92%8cbilprevda\/28130\",\"url\":\"https:\/\/www.franchise.com.hk\/en\/%e5%86%8d%e4%b8%8b%e4%b8%80%e5%9f%8e-%e5%be%a9%e5%ae%8f%e6%bc%a2%e9%9c%96%e8%88%87organon%e5%85%b1%e5%90%8c%e5%ae%a3%e4%bd%88%e5%9c%b0%e8%88%92%e5%96%ae%e6%8a%97bildyos%e5%92%8cbilprevda\/28130\",\"name\":\"\u518d\u4e0b\u4e00\u57ce \u5fa9\u5b8f\u6f22\u9716\u8207Organon\u5171\u540c\u5ba3\u4f48\u5730\u8212\u55ae\u6297BILDYOS\u00ae\u548cBILPREVDA\u00ae\u7372\u6b50\u76df\u6279\u51c6\u4e0a\u5e02 - \u9999\u6e2f\u7279\u8a31\u7d93\u71df\",\"isPartOf\":{\"@id\":\"https:\/\/www.franchise.com.hk\/en#website\"},\"datePublished\":\"2025-09-19T04:32:00+00:00\",\"dateModified\":\"2025-09-19T04:32:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.franchise.com.hk\/en\/%e5%86%8d%e4%b8%8b%e4%b8%80%e5%9f%8e-%e5%be%a9%e5%ae%8f%e6%bc%a2%e9%9c%96%e8%88%87organon%e5%85%b1%e5%90%8c%e5%ae%a3%e4%bd%88%e5%9c%b0%e8%88%92%e5%96%ae%e6%8a%97bildyos%e5%92%8cbilprevda\/28130#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.franchise.com.hk\/en\/%e5%86%8d%e4%b8%8b%e4%b8%80%e5%9f%8e-%e5%be%a9%e5%ae%8f%e6%bc%a2%e9%9c%96%e8%88%87organon%e5%85%b1%e5%90%8c%e5%ae%a3%e4%bd%88%e5%9c%b0%e8%88%92%e5%96%ae%e6%8a%97bildyos%e5%92%8cbilprevda\/28130\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.franchise.com.hk\/en\/%e5%86%8d%e4%b8%8b%e4%b8%80%e5%9f%8e-%e5%be%a9%e5%ae%8f%e6%bc%a2%e9%9c%96%e8%88%87organon%e5%85%b1%e5%90%8c%e5%ae%a3%e4%bd%88%e5%9c%b0%e8%88%92%e5%96%ae%e6%8a%97bildyos%e5%92%8cbilprevda\/28130#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u9996\u9801\",\"item\":\"https:\/\/www.franchise.com.hk\/en\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u518d\u4e0b\u4e00\u57ce \u5fa9\u5b8f\u6f22\u9716\u8207Organon\u5171\u540c\u5ba3\u4f48\u5730\u8212\u55ae\u6297BILDYOS\u00ae\u548cBILPREVDA\u00ae\u7372\u6b50\u76df\u6279\u51c6\u4e0a\u5e02\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.franchise.com.hk\/en#website\",\"url\":\"https:\/\/www.franchise.com.hk\/en\",\"name\":\"\u9999\u6e2f\u7279\u8a31\u7d93\u71df\",\"description\":\"\u9999\u6e2f\u7279\u8a31\u7d93\u71df | Franchise HK\",\"publisher\":{\"@id\":\"https:\/\/www.franchise.com.hk\/en#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.franchise.com.hk\/en?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.franchise.com.hk\/en#organization\",\"name\":\"\u9999\u6e2f\u7279\u8a31\u7d93\u71df\",\"url\":\"https:\/\/www.franchise.com.hk\/en\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.franchise.com.hk\/en#\/schema\/logo\/image\/\",\"url\":\"https:\/\/i0.wp.com\/www.franchise.com.hk\/wp-content\/uploads\/2022\/05\/cropped-cropped-franchise-logo-02-e1652686851566-2.png?fit=350%2C76&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/www.franchise.com.hk\/wp-content\/uploads\/2022\/05\/cropped-cropped-franchise-logo-02-e1652686851566-2.png?fit=350%2C76&ssl=1\",\"width\":350,\"height\":76,\"caption\":\"\u9999\u6e2f\u7279\u8a31\u7d93\u71df\"},\"image\":{\"@id\":\"https:\/\/www.franchise.com.hk\/en#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u518d\u4e0b\u4e00\u57ce \u5fa9\u5b8f\u6f22\u9716\u8207Organon\u5171\u540c\u5ba3\u4f48\u5730\u8212\u55ae\u6297BILDYOS\u00ae\u548cBILPREVDA\u00ae\u7372\u6b50\u76df\u6279\u51c6\u4e0a\u5e02 - \u9999\u6e2f\u7279\u8a31\u7d93\u71df","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.franchise.com.hk\/en\/%e5%86%8d%e4%b8%8b%e4%b8%80%e5%9f%8e-%e5%be%a9%e5%ae%8f%e6%bc%a2%e9%9c%96%e8%88%87organon%e5%85%b1%e5%90%8c%e5%ae%a3%e4%bd%88%e5%9c%b0%e8%88%92%e5%96%ae%e6%8a%97bildyos%e5%92%8cbilprevda\/28130","og_locale":"en_US","og_type":"article","og_title":"\u518d\u4e0b\u4e00\u57ce \u5fa9\u5b8f\u6f22\u9716\u8207Organon\u5171\u540c\u5ba3\u4f48\u5730\u8212\u55ae\u6297BILDYOS\u00ae\u548cBILPREVDA\u00ae\u7372\u6b50\u76df\u6279\u51c6\u4e0a\u5e02 - \u9999\u6e2f\u7279\u8a31\u7d93\u71df","og_description":"\u4e0a\u6d77\u548c\u65b0\u6fa4\u897f\u5dde\u6fa4\u897f\u5e022025\u5e749\u670819\u65e5 \/\u7f8e\u901a\u793e\/ &#8212; \u5fa9\u5b8f\u6f22\u9716\uff082696.HK\uff09\u8207Organon\uff08\u7d10\u4ea4\u6240\u4ee3\u78bc\uff1aOGN\uff09\u4eca\u65e5\u806f\u5408\u5ba3\u4f48\uff0c\u6b50\u76df\u59d4\u54e1\u6703\uff08EC\uff09\u5df2\u6279\u51c6\u5730\u8212\u55ae\u6297\u6ce8\u5c04\u6db2\uff0860 mg\/mL\uff09BILDYOS\u00ae\uff08denosumab\uff09\u548c\u5730\u8212\u55ae\u6297\u6ce8\u5c04\u6db2\uff08120mg\/1.7mL\uff09BILPREVDA\u00ae\uff08denosumab\uff09\u7684\u4e0a\u5e02\u8a31\u53ef\uff0c\u5169\u6b3e\u7522\u54c1\u5206\u5225\u70baPROLIA\u00ae\uff08\u5730\u8212\u55ae\u6297\uff09\u548cXGEVA\u00ae\uff08\u5730\u8212\u55ae\u6297\uff09\u7684\u751f\u7269\u985e\u4f3c\u85e5\uff0c\u8986\u84cb\u539f\u7814\u7522\u54c1\u5728\u6b50\u76df\u5df2\u7372\u6279\u7684\u6240\u6709\u9069\u61c9\u75c7[1,2]\u3002 Organon\u570b\u969b\u5546\u696d\u8ca0\u8cac\u4ebaNico Van Hoecke\u8868\u793a\uff1a\u300cBILDYOS\u548cBILPREVDA\u7684\u6b50\u76df\u7372\u6279\uff0c\u6a19\u8a8c\u8457\u6211\u5011\u5728\u70ba\u6578\u767e\u842c\u6b50\u6d32\u60a3\u8005\uff0c\u7279\u5225\u662f\u53d7\u9aa8\u8cea\u758f\u9b06\u75c7\u5f71\u97ff\u6bd4\u4f8b\u66f4\u9ad8\u7684\u5973\u6027\uff0c\u64f4\u5927\u95dc\u9375\u9aa8\u9abc\u5065\u5eb7\u6cbb\u7642\u53ef\u53ca\u6027\u65b9\u9762\u9081\u51fa\u4e86\u95dc\u9375\u4e00\u6b65[3,4]\u3002\u9019\u4e9b\u751f\u7269\u985e\u4f3c\u85e5\u53ef\u70ba\u5305\u62ec\u9aa8\u8cea\u758f\u9b06\u75c7\u5728\u5167\u7684\u9aa8\u8cea\u6d41\u5931\u76f8\u95dc\u7684\u591a\u500b\u6cbb\u7642\u9818\u57df\u63d0\u4f9b\u66f4\u591a\u9078\u64c7\uff0c\u9ad4\u73fe\u4e86Organon\u901a\u904e\u63d0\u5347\u85e5\u7269\u53ef\u53ca\u6027\u4f86\u63a8\u52d5\u5973\u6027\u5065\u5eb7\u7684\u627f\u8afe\u3002\u5728\u7f8e\u570b\u7372\u6279\u4e4b\u5f8c\uff0c\u9019\u6b21\u7684\u6b50\u76df\u6279\u51c6\u4e0d\u50c5\u62d3\u5c55\u4e86\u5169\u6b3e\u751f\u7269\u985e\u4f3c\u85e5\u7684\u5168\u7403\u53ef\u53ca\u7bc4\u570d\uff0c\u540c\u6642\u4e5f\u652f\u6301\u4e86\u6b50\u6d32\u91ab\u7642\u9ad4\u7cfb\u7684\u53ef\u6301\u7e8c\u767c\u5c55[5,6]\u3002\u300d \u5fa9\u5b8f\u6f22\u9716\u9996\u5e2d\u5546\u52d9\u767c\u5c55\u5b98\u517c\u9ad8\u7d1a\u526f\u7e3d\u88c1\u66f9\u5e73\u8868\u793a\uff1a\u300c\u6b64\u6b21\u7372\u6279\u662f\u5fa9\u5b8f\u6f22\u9716\u8207Organon\u5f37\u5f37\u806f\u5408\u3001\u5171\u540c\u6eff\u8db3\u6b50\u6d32\u60a3\u8005\u548c\u91ab\u7642\u7cfb\u7d71\u9700\u6c42\u7684\u53c8\u4e00\u91cd\u8981\u6210\u679c\u3002\u6191\u501f\u5c0d\u79d1\u5b78\u5353\u8d8a\u8207\u7522\u54c1\u8cea\u91cf\u7684\u59cb\u7d42\u5805\u5b88\uff0c\u6211\u5011\u5728\u7f8e\u570b\u7372\u6279\u7684\u57fa\u790e\u4e0a\u4e0d\u65b7\u524d\u884c\uff0c\u5c07\u9019\u4e9b\u751f\u7269\u985e\u4f3c\u85e5\u6cbb\u7642\u65b9\u6848\u5e36\u7d66\u5168\u7403\u66f4\u591a\u6709\u9700\u8981\u7684\u60a3\u8005[6]\u3002\u300d BILDYOS\u9069\u7528\u6cbb\u7642\u9aa8\u6298\u9ad8\u98a8\u96aa\u7684\u7d55\u7d93\u5f8c\u5a66\u5973\u53ca\u7537\u6027\u7684\u9aa8\u8cea\u758f\u9b06\u75c7\uff1b\u9aa8\u6298\u9ad8\u98a8\u96aa\u7684\u524d\u5217\u817a\u764c\u7537\u6027\u56e0\u6fc0\u7d20\u525d\u596a\u5c0e\u81f4\u7684\u9aa8\u8cea\u6d41\u5931\uff1b\u4ee5\u53ca\u9aa8\u6298\u9ad8\u98a8\u96aa\u6210\u5e74\u60a3\u8005\u56e0\u9577\u671f\u5168\u8eab\u7cd6\u76ae\u8cea\u6fc0\u7d20\u6cbb\u7642\u5c0e\u81f4\u7684\u9aa8\u8cea\u6d41\u5931\u3002BILPREVDA\u9069\u7528\u65bc\u9810\u9632\u7d2f\u53ca\u9aa8\u9abc\u7684\u665a\u671f\u60e1\u6027\u816b\u7624\u6210\u4eba\u7684\u9aa8\u76f8\u95dc\u4e8b\u4ef6\uff0c\u4ee5\u53ca\u6cbb\u7642\u4e0d\u53ef\u624b\u8853\u5207\u9664\u6216\u624b\u8853\u5207\u9664\u5f8c\u53ef\u80fd\u5c0e\u81f4\u56b4\u91cd\u529f\u80fd\u969c\u7919\u7684\u9aa8\u9245\u7d30\u80de\u7624\u60a3\u8005\uff0c\u5305\u62ec\u6210\u4eba\u548c\u9aa8\u9abc\u767c\u80b2\u6210\u719f\u7684\u9752\u5c11\u5e74\u60a3\u8005\u3002 BILDYOS\u548cBILPREVDA\u7684\u7372\u6279\u662f\u57fa\u65bc\u4e00\u6574\u5957\u5168\u9762\u6578\u64da\u7684\u5be9\u67e5\uff0c\u5176\u4e2d\u5305\u62ec\u7d50\u69cb\u8207\u529f\u80fd\u5206\u6790\u6578\u64da\u3001\u81e8\u5e8a\u85e5\u4ee3\u52d5\u529b\u5b78\u6578\u64da\uff0c\u4ee5\u53ca\u4e00\u9805\u81e8\u5e8a\u5c0d\u6bd4\u7814\u7a76\u3002\u7814\u7a76\u8868\u660e\uff0cBILDYOS\u548cBILPREVDA\u5728\u7d50\u69cb\u3001\u751f\u7269\u6d3b\u6027\u4ee5\u53ca\u7642\u6548\u3001\u5b89\u5168\u6027\u548c\u514d\u75ab\u539f\u6027\u7279\u5fb5\uff08\u86cb\u767d\u548c\u5176\u4ed6\u751f\u7269\u85e5\u7269\u8a98\u767c\u514d\u75ab\u61c9\u7b54\u6216\u514d\u75ab\u76f8\u95dc\u4e8b\u4ef6\u7684\u80fd\u529b\uff09\u65b9\u9762\u8207\u6b50\u76df\u5df2\u6279\u51c6\u7684\u53e6\u4e00\u7a2e\u751f\u7269\u85e5\uff08\u5373\u300c\u539f\u7814\u7522\u54c1\u300d\uff09\u9ad8\u5ea6\u76f8\u4f3c\u3002 2022\u5e74\uff0c\u5fa9\u5b8f\u6f22\u9716\u8207Organon\u7c3d\u8a02\u8a31\u53ef\u8207\u4f9b\u61c9\u5354\u8b70\uff0c\u6388\u4e88Organon\u5c0d\u5305\u62ecBILDYOS\u548cBILPREVDA\u5728\u5167\u7684\u591a\u500b\u751f\u7269\u985e\u4f3c\u85e5\u5728\u9664\u4e2d\u570b\u4ee5\u5916\u7684\u5168\u7403\u5340\u57df\u7684\u7368\u5bb6\u5546\u696d\u5316\u6b0a\u76ca[7]\u3002 \u53c3\u8003\u6587\u737b\uff1a PROLIA. Product Information. Amgen; 2025. XGEVA. Product Information. Amgen; 2025. J. Kanis, Norton, N., Harvey, N., et al. SCOPE 2021: a new scorecard for osteoporosis in Europe. Archives of Osteoporosis. (2021) 16:82. Accessed September 15, 2025. Available at https:\/\/www.osteoporosis.foundation\/sites\/iofbonehealth\/files\/202106\/Kanis2021_Article_SCOPE2021ANewScorecardForOsteo.pdf Biosimilar medicines: overview. European Medicines Agency (EMA). April 2, 2025. Accessed September 15, 2025. https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/biosimilar-medicines-overview.\u00a0 Troein P, Max Newton, Stoddart K, Travaglio M, Aurelio Arias. The impact of biosimilar competition in Europe. 2025. Accessed September 15, 2025. https:\/\/www.iqvia.com\/-\/media\/iqvia\/pdfs\/library\/white-papers\/the-impact-of-biosimilar-competition-in-europe-2024.pdf.\u00a0 US Food and Drug Administration (FDA) Approves Henlius and Organon&#8217;s BILDYOS\u00ae (denosumab-nxxp) and BILPREVDA\u00ae (denosumab-nxxp), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively. Organon. Published September 2, 2025. Accessed September 15, 2025.\u00a0https:\/\/www.organon.com\/news\/us-food-and-drug-administration-fda-approves-henlius-and-organons-bildyos-denosumab-nxxp-and-bilprevda-denosumab-nxxp-biosimilars-to-prolia-denosumab-and-xgeva-denosumab\/ Organon Enters into Global License Agreement to Commercialize Henlius&#8217; Investigational Perjeta\u00a0\u00ae(Pertuzumab) and Prolia \u00ae\/Xgeva \u00ae(Denosumab) Biosimilar Candidates. Organon. June 13, 2022. Accessed September 15, 2025. https:\/\/www.organon.com\/news\/organon-enters-into-global-license-agreement-to-commercialize-henlius-investigational-perjeta-pertuzumab-and-prolia-xgeva-denosumab-biosimilar-candidates\/\u00a0 \u95dc\u65bc\u5fa9\u5b8f\u6f22\u9716 \u5fa9\u5b8f\u6f22\u9716\uff082696.HK\uff09\u662f\u4e00\u5bb6\u570b\u969b\u5316\u7684\u5275\u65b0\u751f\u7269\u88fd\u85e5\u516c\u53f8\uff0c\u81f4\u529b\u65bc\u70ba\u5168\u7403\u60a3\u8005\u63d0\u4f9b\u53ef\u8ca0\u64d4\u7684\u9ad8\u54c1\u8cea\u751f\u7269\u85e5\uff0c\u7522\u54c1\u8986\u84cb\u816b\u7624\u3001\u81ea\u8eab\u514d\u75ab\u75be\u75c5\u3001\u773c\u79d1\u75be\u75c5\u7b49\u9818\u57df\uff0c\u5df2\u5728\u5168\u7403\u7372\u6279\u4e0a\u5e029\u6b3e\u7522\u54c1\uff0c4\u500b\u4e0a\u5e02\u7533\u8acb\u5206\u5225\u7372\u4e2d\u570b\u85e5\u76e3\u5c40\u3001\u7f8e\u570bFDA\u548c\u6b50\u76dfEMA\u53d7\u7406\u3002\u81ea2010\u5e74\u6210\u7acb\u4ee5\u4f86\uff0c\u5fa9\u5b8f\u6f22\u9716\u5df2\u5efa\u6210\u4e00\u9ad4\u5316\u751f\u7269\u88fd\u85e5\u5e73\u53f0\uff0c\u9ad8\u6548\u53ca\u5275\u65b0\u7684\u81ea\u4e3b\u6838\u5fc3\u80fd\u529b\u8cab\u7a7f\u7814\u767c\u3001\u751f\u7522\u53ca\u5546\u696d\u904b\u71df\u5168\u7522\u696d\u93c8\u3002\u516c\u53f8\u5df2\u5efa\u7acb\u5b8c\u5584\u9ad8\u6548\u7684\u5168\u7403\u5275\u65b0\u4e2d\u5fc3\uff0c\u6309\u7167\u570b\u969b\u85e5\u54c1\u751f\u7522\u8cea\u91cf\u7ba1\u7406\u898f\u7bc4\uff08GMP\uff09\u6a19\u6e96\u9032\u884c\u751f\u7522\u548c\u8cea\u91cf\u7ba1\u63a7\uff0c\u4e0d\u65b7\u592f\u5be6\u4e00\u9ad4\u5316\u7d9c\u5408\u751f\u7522\u5e73\u53f0\uff0c\u5176\u4e2d\uff0c\u516c\u53f8\u5546\u696d\u5316\u751f\u7522\u57fa\u5730\u5df2\u76f8\u7e7c\u7372\u5f97\u4e2d\u570b\u3001\u6b50\u76df\u548c\u7f8e\u570bGMP\u8a8d\u8b49\u3002 \u5fa9\u5b8f\u6f22\u9716\u524d\u77bb\u6027\u4f48\u5c40\u4e86\u4e00\u500b\u591a\u5143\u5316\u3001\u9ad8\u8cea\u91cf\u7684\u7522\u54c1\u7ba1\u7dda\uff0c\u6db5\u84cb\u7d0450\u500b\u5206\u5b50\uff0c\u4e26\u5168\u9762\u63a8\u9032\u57fa\u65bc\u81ea\u6709\u6297PD-1\u55ae\u6297H\u85e5\u6f22\u65af\u72c0\u00ae\u7684\u816b\u7624\u514d\u75ab\u806f\u5408\u7642\u6cd5\u3002\u622a\u81f3\u76ee\u524d\uff0c\u516c\u53f8\u5df2\u7372\u6279\u4e0a\u5e02\u7522\u54c1\u5305\u62ec\u5168\u7403\u9996\u500b\u7372\u6279\u4e00\u7dda\u6cbb\u7642\u5c0f\u7d30\u80de\u80ba\u764c\u7684\u6297PD-1\u55ae\u6297\u6f22\u65af\u72c0\u00ae\uff08\u65af\u9b6f\u5229\u55ae\u6297\uff0c\u6b50\u6d32\u5546\u54c1\u540d\uff1aHetronifly\u00ae\uff09\u3001\u81ea\u4e3b\u7814\u767c\u7684\u4e2d\u7f8e\u6b50\u4e09\u5730\u7372\u6279\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5\u6f22\u66f2\u512a\u00ae\uff08\u66f2\u59a5\u73e0\u55ae\u6297\uff0c\u7f8e\u570b\u5546\u54c1\u540d\uff1aHERCESSI\u2122\uff0c\u6b50\u6d32\u5546\u54c1\u540d\uff1aZercepac\u00ae\uff09\u3001\u570b\u5167\u9996\u500b\u751f\u7269\u985e\u4f3c\u85e5\u6f22\u5229\u5eb7\u00ae\uff08\u5229\u59a5\u6614\u55ae\u6297\uff09\u3001\u4ee5\u53ca\u5730\u8212\u55ae\u6297\u751f\u7269\u985e\u4f3c\u85e5Bildyos\u00ae\u548cBilprevda\u00ae\u3002\u516c\u53f8\u4ea6\u540c\u6b65\u5c3119\u500b\u7522\u54c1\u5728\u5168\u7403\u7bc4\u570d\u5167\u958b\u5c5530\u591a\u9805\u81e8\u5e8a\u8a66\u9a57\uff0c\u5c0d\u5916\u6388\u6b0a\u5168\u9762\u8986\u84cb\u6b50\u7f8e\u4e3b\u6d41\u751f\u7269\u85e5\u5e02\u5834\u548c\u773e\u591a\u65b0\u8208\u5e02\u5834\u3002 \u95dc\u65bc Organon Organon\uff08\u7d10\u7d04\u8b49\u5238\u4ea4\u6613\u6240\u4ee3\u78bc\uff1aOGN\uff09\u662f\u4e00\u5bb6\u5168\u7403\u5316\u91ab\u7642\u5065\u5eb7\u516c\u53f8\uff0c\u4f7f\u547d\u662f\u63d0\u4f9b\u6709\u6df1\u9060\u5f71\u97ff\u7684\u85e5\u7269\u8207\u89e3\u6c7a\u65b9\u6848\uff0c\u8b93\u4eba\u5011\u7684\u6bcf\u4e00\u5929\u66f4\u5065\u5eb7\u3002\u516c\u53f8\u5c08\u6ce8\u65bc\u89e3\u6c7a\u7368\u7279\uff0c\u91cd\u9ede\uff0c\u6216\u4ee5\u4e0d\u540c\u65b9\u5f0f\u5f71\u97ff\u5973\u6027\u7684\u5065\u5eb7\u9700\u6c42\uff0c\u63d0\u4f9b\u8d85\u904e70\u7a2e\u5973\u6027\u5065\u5eb7\u8207\u5e38\u898f\u85e5\u7269\u7684\u7522\u54c1\u7d44\u5408\uff0c\u5176\u4e2d\u5305\u62ec\u751f\u7269\u985e\u4f3c\u85e5\uff0c\u540c\u6642\u5728\u5168\u7403140\u591a\u500b\u5e02\u5834\u64f4\u5927\u57fa\u672c\u6cbb\u7642\u624b\u6bb5\u7684\u53ef\u53ca\u6027\u3002 \u516c\u53f8\u7e3d\u90e8\u4f4d\u65bc\u65b0\u6fa4\u897f\u5dde\u6fa4\u897f\u5e02\u3002Organon \u81f4\u529b\u65bc\u63a8\u52d5\u91ab\u7642\u7684\u53ef\u53ca\u6027\u3001\u53ef\u8ca0\u64d4\u6027\u8207\u5275\u65b0\u3002\u66f4\u591a\u4fe1\u606f\u8acb\u8a2a\u554f www.organon.com\uff0c\u4e26\u95dc\u6ce8\u6211\u5011\u7684 LinkedIn\u3001Instagram\u3001X\u3001YouTube\u3001TikTok \u548c Facebook\u3002 \u95dc\u65bc\u524d\u77bb\u6027\u8072\u660e\u7684\u6ce8\u610f\u4e8b\u9805 \u9664\u6b77\u53f2\u4fe1\u606f\u5916\uff0c\u672c\u65b0\u805e\u7a3f\u5305\u542b\u7684\u67d0\u4e9b\u9673\u8ff0\u548c\u62ab\u9732\u5c6c\u65bc1995\u5e74\u300a\u7f8e\u570b\u79c1\u4eba\u8b49\u5238\u8a34\u8a1f\u6539\u9769\u6cd5\u6848\u300b\u5b89\u5168\u6e2f\u689d\u6b3e\u6240\u6307\u7684\u300c\u524d\u77bb\u6027\u9673\u8ff0\u300d\uff0c\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\u6709\u95dcBILDYOS\u548cBILPREVDA\u696d\u52d9\u6a5f\u6703\u53ca\u5e02\u5834\u524d\u666f\u9810\u671f\u7684\u76f8\u95dc\u8868\u8ff0\u3002\u524d\u77bb\u6027\u9673\u8ff0\u53ef\u901a\u904e\u300c\u5c07\u6703\u300d\u3001\u300c\u6f5b\u5728\u300d\u3001\u300c\u76ee\u6a19\u300d\u3001\u300c\u63a2\u7d22\u300d\u3001\u300c\u6a5f\u6703\u300d\u3001\u300c\u9810\u671f\u300d\u3001\u300c\u672a\u4f86\u300d\u6216\u5177\u6709\u985e\u4f3c\u542b\u7fa9\u7684\u63aa\u8fad\u8b58\u5225\u3002\u9019\u4e9b\u524d\u77bb\u6027\u9673\u8ff0\u57fa\u65bcOrganon\u7ba1\u7406\u5c64\u7576\u524d\u7684\u8a08\u5283\u548c\u9810\u671f\uff0c\u4e26\u53d7\u5230\u91cd\u5927\u98a8\u96aa\u548c\u4e0d\u78ba\u5b9a\u6027\u7684\u5f71\u97ff\uff0c\u5982\u57fa\u672c\u5047\u5b9a\u4e0d\u6e96\u78ba\u6216\u98a8\u96aa\u6216\u4e0d\u78ba\u5b9a\u6027\u6210\u70ba\u73fe\u5be6\uff0c\u5be6\u969b\u7d50\u679c\u53ef\u80fd\u8207\u524d\u77bb\u6027\u8072\u660e\u4e2d\u6240\u8ff0\u7684\u7d50\u679c\u6709\u91cd\u5927\u5dee\u7570\u3002\u98a8\u96aa\u548c\u4e0d\u78ba\u5b9a\u6027\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\uff1a\u7121\u6cd5\u63a8\u5ee3 BILDYOS \u548c BILPREVDA\uff1b\u53ef\u80fd\u4e0d\u5229\u5f71\u97ff\u5176\u5e02\u5834\u9700\u6c42\u7684\u56e0\u7d20\uff08\u5305\u62ec\u8cbf\u6613\u4fdd\u8b77\u63aa\u65bd\u53ca\u9032\u51fa\u53e3\u8a31\u53ef\u8981\u6c42\u3001\u7f8e\u570b\u53ca\u5176\u4ed6\u570b\u5bb6\u6216\u5730\u5340\u5728\u806f\u90a6\u3001\u5dde\u53ca\u5730\u65b9\u5c64\u9762\u7684\u653f\u5e9c\u8cc7\u91d1\u5206\u914d\u8b8a\u5316\u2014\u2014\u5305\u62ec\u5206\u914d\u7d66 Organon \u5ba2\u6236\u53ca\u696d\u52d9\u5925\u4f34\u7684\u6642\u9593\u548c\u91d1\u984d\uff0c\u4ee5\u53ca\u7d93\u6fdf\u56e0\u7d20\uff09\uff1b\u4efb\u4f55\u4f9b\u61c9\u5546\u672a\u80fd\u6309\u7d04\u63d0\u4f9b\u7269\u8cea\u3001\u6750\u6599\u6216\u670d\u52d9\uff1b\u4f9b\u61c9\u3001\u751f\u7522\u3001\u5305\u88dd\u548c\u904b\u71df\u6210\u672c\u7684\u589e\u52a0\uff1b\u5168\u7403\u7bc4\u570d\u5167\u7684\u5b9a\u50f9\u58d3\u529b\uff0c\u5305\u62ec\u91ab\u7642\u4fdd\u96aa\u7ba1\u7406\u7d44\u7e54\u7684\u898f\u5247\u8207\u505a\u6cd5\u3001\u53f8\u6cd5\u5224\u6c7a\u4ee5\u53ca\u8207\u91ab\u4fdd\uff08Medicare\uff09\u3001\u91ab\u7642\u88dc\u52a9\uff08Medicaid\uff09\u53ca\u91ab\u7642\u6539\u9769\u76f8\u95dc\u7684\u653f\u5e9c\u6cd5\u5f8b\u6cd5\u898f\uff0c\u4ee5\u53ca\u85e5\u54c1\u88dc\u511f\u8207\u5b9a\u50f9\u7e3d\u9ad4\u74b0\u5883\uff1b\u751f\u7522\u56f0\u96e3\u6216\u5ef6\u9072\uff1b\u7f8e\u570b FDA \u6216\u5176\u4ed6\u653f\u5e9c\u6a5f\u69cb\u7684\u91cd\u7d44\u6216\u5176\u4ed6\u5e72\u64fe\uff1b\u7642\u6548\u3001\u5b89\u5168\u6027\u6216\u5176\u4ed6\u8cea\u91cf\u65b9\u9762\u7684\u9867\u616e\uff1b\u4ee5\u53ca\u7b2c\u4e09\u65b9\u672a\u4f86\u7684\u884c\u52d5\uff0c\u5305\u62ec\u5ba2\u6236\u95dc\u4fc2\u7684\u91cd\u5927\u8b8a\u5316\uff0c\u6216\u91ab\u7642\u7522\u54c1\u8207\u670d\u52d9\u8cfc\u8cb7\u8005\u7684\u884c\u70ba\u8207\u6d88\u8cbb\u6a21\u5f0f\u7684\u8b8a\u5316\uff0c\u4f8b\u5982\u63a8\u9072\u91ab\u7642\u7a0b\u5e8f\u3001\u9650\u5236\u8655\u65b9\u85e5\u4f7f\u7528\u3001\u6e1b\u5c11\u5c31\u8a3a\u983b\u7387\uff0c\u4ee5\u53ca\u653e\u68c4\u91ab\u7642\u4fdd\u96aa\u8986\u84cb\u7b49\u3002Organon \u6c92\u6709\u7fa9\u52d9\u56e0\u65b0\u4fe1\u606f\u3001\u672a\u4f86\u4e8b\u4ef6\u6216\u5176\u4ed6\u539f\u56e0\u800c\u516c\u958b\u66f4\u65b0\u4efb\u4f55\u524d\u77bb\u6027\u8072\u660e\u3002\u5c0e\u81f4\u7d50\u679c\u8207\u524d\u77bb\u6027\u8072\u660e\u6240\u8ff0\u5b58\u5728\u91cd\u5927\u5dee\u7570\u7684\u5176\u4ed6\u56e0\u7d20\uff0c\u53ef\u898b\u65bc Organon \u5411\u7f8e\u570b\u8b49\u5238\u4ea4\u6613\u59d4\u54e1\u6703\uff08SEC\uff09\u63d0\u4ea4\u7684\u6587\u4ef6\uff0c\u5305\u62ec Organon \u6700\u65b0\u7684\u5e74\u5ea6\u5831\u544a Form 10-K \u53ca\u5176\u5f8c\u7e8c\u6587\u4ef6\uff08\u5305\u62ec\u622a\u81f3 2025 \u5e74 6 \u6708 30 \u65e5\u5b63\u5ea6\u7684\u5b63\u5ea6\u5831\u544a Form 10-Q\uff09\uff0c\u53ef\u5728 SEC \u7db2\u7ad9 (www.sec.gov) \u67e5\u95b1\u3002\u6240\u63d0\u4f9b\u7684\u53c3\u8003\u8207\u7db2\u7ad9\u93c8\u63a5\u50c5\u70ba\u65b9\u4fbf\u8d77\u898b\uff0c\u4efb\u4f55\u6b64\u985e\u7db2\u7ad9\u6240\u8f09\u4fe1\u606f\u5747\u4e0d\u69cb\u6210\u672c\u65b0\u805e\u7a3f\u7684\u4e00\u90e8\u5206\uff0c\u4e5f\u4e0d\u88ab\u8996\u70ba\u5f15\u7528\u4f75\u5165\u672c\u65b0\u805e\u7a3f\u3002Organon \u5c0d\u7b2c\u4e09\u65b9\u7db2\u7ad9\u5167\u5bb9\u4e0d\u627f\u64d4\u8cac\u4efb\u3002 PROLIA \u548c XGEVA \u70ba\u5b89\u9032\u516c\u53f8\uff08Amgen, Inc.\uff09\u5728\u6b50\u6d32\u8a3b\u518a\u7684\u5546\u6a19\uff1bOrganon \u8207\u8a72\u5546\u6a19\u6301\u6709\u4eba\u4e0d\u5b58\u5728\u4efb\u4f55\u95dc\u806f\u3002","og_url":"https:\/\/www.franchise.com.hk\/en\/%e5%86%8d%e4%b8%8b%e4%b8%80%e5%9f%8e-%e5%be%a9%e5%ae%8f%e6%bc%a2%e9%9c%96%e8%88%87organon%e5%85%b1%e5%90%8c%e5%ae%a3%e4%bd%88%e5%9c%b0%e8%88%92%e5%96%ae%e6%8a%97bildyos%e5%92%8cbilprevda\/28130","og_site_name":"\u9999\u6e2f\u7279\u8a31\u7d93\u71df","article_published_time":"2025-09-19T04:32:00+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.franchise.com.hk\/en\/%e5%86%8d%e4%b8%8b%e4%b8%80%e5%9f%8e-%e5%be%a9%e5%ae%8f%e6%bc%a2%e9%9c%96%e8%88%87organon%e5%85%b1%e5%90%8c%e5%ae%a3%e4%bd%88%e5%9c%b0%e8%88%92%e5%96%ae%e6%8a%97bildyos%e5%92%8cbilprevda\/28130#article","isPartOf":{"@id":"https:\/\/www.franchise.com.hk\/en\/%e5%86%8d%e4%b8%8b%e4%b8%80%e5%9f%8e-%e5%be%a9%e5%ae%8f%e6%bc%a2%e9%9c%96%e8%88%87organon%e5%85%b1%e5%90%8c%e5%ae%a3%e4%bd%88%e5%9c%b0%e8%88%92%e5%96%ae%e6%8a%97bildyos%e5%92%8cbilprevda\/28130"},"author":{"name":"","@id":""},"headline":"\u518d\u4e0b\u4e00\u57ce \u5fa9\u5b8f\u6f22\u9716\u8207Organon\u5171\u540c\u5ba3\u4f48\u5730\u8212\u55ae\u6297BILDYOS\u00ae\u548cBILPREVDA\u00ae\u7372\u6b50\u76df\u6279\u51c6\u4e0a\u5e02","datePublished":"2025-09-19T04:32:00+00:00","dateModified":"2025-09-19T04:32:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.franchise.com.hk\/en\/%e5%86%8d%e4%b8%8b%e4%b8%80%e5%9f%8e-%e5%be%a9%e5%ae%8f%e6%bc%a2%e9%9c%96%e8%88%87organon%e5%85%b1%e5%90%8c%e5%ae%a3%e4%bd%88%e5%9c%b0%e8%88%92%e5%96%ae%e6%8a%97bildyos%e5%92%8cbilprevda\/28130"},"wordCount":243,"publisher":{"@id":"https:\/\/www.franchise.com.hk\/en#organization"},"articleSection":["\u672a\u5206\u985e"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.franchise.com.hk\/en\/%e5%86%8d%e4%b8%8b%e4%b8%80%e5%9f%8e-%e5%be%a9%e5%ae%8f%e6%bc%a2%e9%9c%96%e8%88%87organon%e5%85%b1%e5%90%8c%e5%ae%a3%e4%bd%88%e5%9c%b0%e8%88%92%e5%96%ae%e6%8a%97bildyos%e5%92%8cbilprevda\/28130","url":"https:\/\/www.franchise.com.hk\/en\/%e5%86%8d%e4%b8%8b%e4%b8%80%e5%9f%8e-%e5%be%a9%e5%ae%8f%e6%bc%a2%e9%9c%96%e8%88%87organon%e5%85%b1%e5%90%8c%e5%ae%a3%e4%bd%88%e5%9c%b0%e8%88%92%e5%96%ae%e6%8a%97bildyos%e5%92%8cbilprevda\/28130","name":"\u518d\u4e0b\u4e00\u57ce \u5fa9\u5b8f\u6f22\u9716\u8207Organon\u5171\u540c\u5ba3\u4f48\u5730\u8212\u55ae\u6297BILDYOS\u00ae\u548cBILPREVDA\u00ae\u7372\u6b50\u76df\u6279\u51c6\u4e0a\u5e02 - \u9999\u6e2f\u7279\u8a31\u7d93\u71df","isPartOf":{"@id":"https:\/\/www.franchise.com.hk\/en#website"},"datePublished":"2025-09-19T04:32:00+00:00","dateModified":"2025-09-19T04:32:00+00:00","breadcrumb":{"@id":"https:\/\/www.franchise.com.hk\/en\/%e5%86%8d%e4%b8%8b%e4%b8%80%e5%9f%8e-%e5%be%a9%e5%ae%8f%e6%bc%a2%e9%9c%96%e8%88%87organon%e5%85%b1%e5%90%8c%e5%ae%a3%e4%bd%88%e5%9c%b0%e8%88%92%e5%96%ae%e6%8a%97bildyos%e5%92%8cbilprevda\/28130#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.franchise.com.hk\/en\/%e5%86%8d%e4%b8%8b%e4%b8%80%e5%9f%8e-%e5%be%a9%e5%ae%8f%e6%bc%a2%e9%9c%96%e8%88%87organon%e5%85%b1%e5%90%8c%e5%ae%a3%e4%bd%88%e5%9c%b0%e8%88%92%e5%96%ae%e6%8a%97bildyos%e5%92%8cbilprevda\/28130"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.franchise.com.hk\/en\/%e5%86%8d%e4%b8%8b%e4%b8%80%e5%9f%8e-%e5%be%a9%e5%ae%8f%e6%bc%a2%e9%9c%96%e8%88%87organon%e5%85%b1%e5%90%8c%e5%ae%a3%e4%bd%88%e5%9c%b0%e8%88%92%e5%96%ae%e6%8a%97bildyos%e5%92%8cbilprevda\/28130#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u9996\u9801","item":"https:\/\/www.franchise.com.hk\/en"},{"@type":"ListItem","position":2,"name":"\u518d\u4e0b\u4e00\u57ce \u5fa9\u5b8f\u6f22\u9716\u8207Organon\u5171\u540c\u5ba3\u4f48\u5730\u8212\u55ae\u6297BILDYOS\u00ae\u548cBILPREVDA\u00ae\u7372\u6b50\u76df\u6279\u51c6\u4e0a\u5e02"}]},{"@type":"WebSite","@id":"https:\/\/www.franchise.com.hk\/en#website","url":"https:\/\/www.franchise.com.hk\/en","name":"\u9999\u6e2f\u7279\u8a31\u7d93\u71df","description":"\u9999\u6e2f\u7279\u8a31\u7d93\u71df | Franchise HK","publisher":{"@id":"https:\/\/www.franchise.com.hk\/en#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.franchise.com.hk\/en?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.franchise.com.hk\/en#organization","name":"\u9999\u6e2f\u7279\u8a31\u7d93\u71df","url":"https:\/\/www.franchise.com.hk\/en","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.franchise.com.hk\/en#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/www.franchise.com.hk\/wp-content\/uploads\/2022\/05\/cropped-cropped-franchise-logo-02-e1652686851566-2.png?fit=350%2C76&ssl=1","contentUrl":"https:\/\/i0.wp.com\/www.franchise.com.hk\/wp-content\/uploads\/2022\/05\/cropped-cropped-franchise-logo-02-e1652686851566-2.png?fit=350%2C76&ssl=1","width":350,"height":76,"caption":"\u9999\u6e2f\u7279\u8a31\u7d93\u71df"},"image":{"@id":"https:\/\/www.franchise.com.hk\/en#\/schema\/logo\/image\/"}}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.franchise.com.hk\/en\/wp-json\/wp\/v2\/posts\/28130"}],"collection":[{"href":"https:\/\/www.franchise.com.hk\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.franchise.com.hk\/en\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.franchise.com.hk\/en\/wp-json\/wp\/v2\/comments?post=28130"}],"version-history":[{"count":0,"href":"https:\/\/www.franchise.com.hk\/en\/wp-json\/wp\/v2\/posts\/28130\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.franchise.com.hk\/en\/wp-json\/wp\/v2\/media?parent=28130"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.franchise.com.hk\/en\/wp-json\/wp\/v2\/categories?post=28130"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.franchise.com.hk\/en\/wp-json\/wp\/v2\/tags?post=28130"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}